Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   liver disease
  

Disease ID 675
Disease liver disease
Definition
Pathological processes of the LIVER.
Synonym
[x]diseases of the liver
[x]diseases of the liver (disorder)
disease hepatocellular
disease of liver
disease of liver (disorder)
disease of liver [ambiguous]
disease of liver, nos
disease, liver
diseases of liver
diseases of the liver
diseases, liver
disorder hepatic
disorder liver
disorder of liver
disorder of liver (disorder)
fector hepaticus
hepatic disease
hepatic disease (nos)
hepatic diseases
hepatic disorder
hepatic disorder (nos)
hepatic disorders
hepatic: hepatocellular
hepatocellular disease
hepatopathy
ld - liver disease
liver and intrahepatic bile duct disorder
liver dis
liver disease, nos
liver diseases
liver diseases [disease/finding]
liver diseases of
liver disorder
liver disorder nos
liver disorder nos (disorder)
liver disorders
liver--diseases
unspecified disorder of liver
DOID
UMLS
C0023895
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:319)
C0023890  |  cirrhosis  |  175
C0019158  |  hepatitis  |  144
C0028754  |  obesity  |  83
C0019204  |  hepatocellular carcinoma  |  82
C0011847  |  diabetes  |  70
C0019196  |  hepatitis c  |  69
C0020538  |  hypertension  |  63
C0020541  |  portal hypertension  |  56
C0948265  |  metabolic syndrome  |  52
C0019163  |  hepatitis b  |  50
C0011860  |  type 2 diabetes  |  45
C0011849  |  diabetes mellitus  |  25
C0023890  |  liver cirrhosis  |  25
C0040034  |  thrombocytopenia  |  22
C0011860  |  type 2 diabetes mellitus  |  21
C0019151  |  hepatic encephalopathy  |  19
C0042721  |  viral hepatitis  |  19
C0042373  |  vascular disease  |  17
C0010674  |  cystic fibrosis  |  16
C0042769  |  virus infection  |  15
C0007222  |  cardiovascular disease  |  15
C0010068  |  coronary artery disease  |  14
C0282193  |  iron overload  |  13
C0042870  |  vitamin d defic  |  12
C0042345  |  varices  |  12
C0042870  |  vitamin d deficiency  |  12
C0022658  |  kidney disease  |  12
C0004153  |  atherosclerosis  |  11
C0162429  |  malnutrition  |  11
C0035078  |  renal failure  |  10
C0029456  |  osteoporosis  |  10
C0040053  |  thrombosis  |  10
C0014867  |  esophageal varices  |  9
C0023903  |  liver cancer  |  9
C0022658  |  renal disease  |  9
C0008370  |  cholestasis  |  8
C0011570  |  depression  |  8
C0020542  |  pulmonary hypertension  |  8
C0007113  |  rectal cancer  |  7
C0021390  |  inflammatory bowel disease  |  7
C0002871  |  anemia  |  7
C0032460  |  polycystic ovary syndrome  |  7
C0032460  |  polycystic ovary  |  7
C0022661  |  chronic kidney disease  |  6
C0008313  |  sclerosing cholangitis  |  6
C0018799  |  heart disease  |  6
C0007570  |  celiac disease  |  6
C0019187  |  alcoholic hepatitis  |  6
C0021831  |  bowel disease  |  6
C0019196  |  hepatitis c infection  |  6
C0241910  |  autoimmune hepatitis  |  6
C0020676  |  hypothyroidism  |  5
C0008311  |  cholangitis  |  5
C0019202  |  wilson's disease  |  5
C0020456  |  hyperglycemia  |  5
C0020532  |  hypersplenism  |  5
C0019202  |  wilson disease  |  5
C0005940  |  bone disease  |  5
C0009402  |  colorectal cancer  |  5
C0024141  |  systemic lupus erythematosus  |  5
C0005411  |  biliary atresia  |  5
C0037061  |  siderosis  |  4
C0008312  |  primary biliary cirrhosis  |  4
C0010068  |  coronary heart disease  |  4
C0600452  |  hepatopulmonary syndrome  |  4
C1565489  |  renal insufficiency  |  4
C0001973  |  alcoholism  |  4
C0014867  |  oesophageal varices  |  4
C0566602  |  primary sclerosing cholangitis  |  4
C0018801  |  heart failure  |  4
C0032285  |  pneumonia  |  4
C0022679  |  cystic kidney  |  4
C0019212  |  hepatorenal syndrome  |  3
C0003467  |  anxiety  |  3
C0042373  |  vascular disorder  |  3
C0162429  |  malnourished  |  3
C0041296  |  tuberculosis  |  3
C0028756  |  morbid obesity  |  3
C0004623  |  bacterial infection  |  3
C0019163  |  hepatitis b infection  |  3
C0022661  |  chronic renal failure  |  3
C0409974  |  lupus erythematosus  |  3
C0008312  |  biliary cirrhosis  |  3
C0206698  |  cholangiocarcinoma  |  3
C0019322  |  umbilical hernia  |  3
C0520679  |  obstructive sleep apnea  |  3
C0159069  |  impaired glucose tolerance  |  3
C0155773  |  portal vein thrombosis  |  3
C0001623  |  adrenal insufficiency  |  3
C0037315  |  sleep apnea  |  3
C0085413  |  autosomal dominant polycystic kidney  |  3
C0023891  |  alcoholic cirrhosis  |  3
C0042373  |  vascular diseases  |  3
C0009319  |  colitis  |  3
C0007222  |  cardiovascular diseases  |  3
C0022661  |  chronic renal disease  |  2
C0033860  |  psoriasis  |  2
C0022661  |  end stage renal disease  |  2
C0442874  |  neuropathy  |  2
C0019204  |  hepatocellular carcinomas  |  2
C0011854  |  type 1 diabetes  |  2
C0007570  |  coeliac disease  |  2
C0042373  |  vascular disorders  |  2
C0023895  |  liver diseases  |  2
C0027765  |  neurological disorder  |  2
C0011226  |  hepatitis d  |  2
C0024523  |  malabsorption  |  2
C0028756  |  severe obesity  |  2
C0004623  |  bacterial infections  |  2
C0017178  |  gastrointestinal disorders  |  2
C0036992  |  short bowel syndrome  |  2
C1561644  |  chronic kidney disease (ckd)  |  2
C0345905  |  intrahepatic cholangiocarcinoma  |  2
C0009324  |  ulcerative colitis  |  2
C0017168  |  esophageal reflux  |  2
C0028754  |  adiposity  |  2
C0018991  |  hemiplegia  |  2
C0007222  |  cardiovascular disorders  |  2
C0035579  |  hypovitaminosis d  |  2
C0039446  |  telangiectasias  |  2
C0034150  |  purpura  |  2
C0032285  |  pneumoniae  |  2
C0017168  |  oesophageal reflux  |  2
C0036323  |  schistosomiasis  |  2
C0016977  |  gallbladder disease  |  2
C1510471  |  hypovitaminosis  |  2
C0856761  |  budd-chiari syndrome  |  2
C0271650  |  prediabetes  |  2
C0011644  |  scleroderma  |  2
C0022661  |  end-stage renal disease  |  2
C0017168  |  gastroesophageal reflux  |  2
C0085413  |  autosomal dominant polycystic kidney disease  |  2
C0005940  |  bone diseases  |  2
C0031154  |  peritonitis  |  2
C0042769  |  viral infection  |  2
C0006142  |  breast cancer  |  2
C0085293  |  hepatitis e  |  2
C0022658  |  nephropathy  |  2
C0017178  |  gastrointestinal disorder  |  2
C0019045  |  hemoglobinopathies  |  2
C0042075  |  urologic disease  |  2
C0020459  |  hyperinsulinemia  |  2
C0851578  |  sleep disorders  |  2
C0002766  |  analgesia  |  2
C0036341  |  schizophrenia  |  2
C0010068  |  coronary disease  |  2
C0004096  |  asthma  |  1
C0020455  |  hypergammaglobulinemia  |  1
C0039730  |  thalassaemia  |  1
C0003873  |  rheumatoid arthritis  |  1
C0398623  |  hypercoagulable state  |  1
C0005586  |  bipolar disorder  |  1
C0206754  |  neuroendocrine tumour  |  1
C0850572  |  colonic adenoma  |  1
C0008370  |  bile stasis  |  1
C0013338  |  growth hormone deficiency  |  1
C0003873  |  rheumatoid disease  |  1
C0162429  |  undernutrition  |  1
C0011226  |  delta infection  |  1
C0022661  |  end stage renal disease (esrd)  |  1
C0155765  |  microangiopathy  |  1
C0017205  |  gaucher disease  |  1
C0042384  |  vasculitis  |  1
C0019045  |  haemoglobinopathies  |  1
C1384514  |  primary aldosteronism  |  1
C0004134  |  ataxia  |  1
C0238198  |  gastrointestinal stromal tumors  |  1
C0021053  |  immune disease  |  1
C0041408  |  turner's syndrome  |  1
C0008049  |  chickenpox  |  1
C0024623  |  gastric cancer  |  1
C0011226  |  hepatitis delta  |  1
C0030312  |  pancytopenia  |  1
C0023903  |  hepatic cancer  |  1
C0008372  |  intrahepatic cholestasis  |  1
C0026718  |  mucormycosis  |  1
C0085253  |  adult onset still's disease  |  1
C0021670  |  insulinoma  |  1
C0014118  |  endocarditis  |  1
C0032914  |  preeclampsia  |  1
C0011860  |  niddm  |  1
C0015930  |  fetal distress  |  1
C0002878  |  haemolytic anaemia  |  1
C0004030  |  aspergillosis  |  1
C0349604  |  intracranial meningioma  |  1
C0018099  |  gout  |  1
C0006309  |  brucellosis  |  1
C0020474  |  familial combined hyperlipidemia  |  1
C0028709  |  nutrition disorders  |  1
C0085762  |  ethanol abuse  |  1
C0023895  |  liver disorders  |  1
C0015645  |  fasciitis  |  1
C0009492  |  compartment syndrome  |  1
C0023903  |  hepatic tumor  |  1
C0221757  |  alpha-1-antitrypsin def  |  1
C0011860  |  type ii diabetes  |  1
C0021053  |  immune disorders  |  1
C0206754  |  neuroendocrine tumors  |  1
C0162429  |  nutritional deficiencies  |  1
C0494165  |  liver metastasis  |  1
C0021843  |  bowel obstruction  |  1
C0024314  |  lymphoproliferative disorder  |  1
C0033677  |  protein-energy malnutrition  |  1
C0014735  |  erysipelothrix  |  1
C0008350  |  cholelithiasis  |  1
C0206754  |  neuroendocrine tumor  |  1
C0036319  |  schistosoma mansoni  |  1
C0149521  |  chronic pancreatitis  |  1
C0002878  |  hemolytic anemia  |  1
C0029442  |  osteomalacia  |  1
C0022661  |  end-stage renal failure  |  1
C0015230  |  rash  |  1
C0027765  |  neurologic disorder  |  1
C0162429  |  nutritional deficiency  |  1
C0031090  |  periodontal disease  |  1
C1619734  |  pulmonary arterial hypertension  |  1
C0011633  |  dermatomyositis  |  1
C0023895  |  liver disorder  |  1
C0023241  |  legionella pneumonia  |  1
C0021390  |  inflammatory bowel diseases  |  1
C0268483  |  tyrosinemia  |  1
C0349604  |  intracranial meningiomas  |  1
C1145670  |  respiratory failure  |  1
C0010631  |  cystadenocarcinoma  |  1
C0019621  |  langerhans cell histiocytosis  |  1
C0018920  |  cavernoma  |  1
C0021053  |  immune disorder  |  1
C0398623  |  hypercoagulability  |  1
C0037317  |  sleep disturbance  |  1
C0017665  |  membranous nephropathy  |  1
C0259749  |  autonomic neuropathy  |  1
C0085681  |  hyperphosphatemia  |  1
C0751711  |  anterior ischemic optic neuropathy  |  1
C0036337  |  schizoaffective disorder  |  1
C0010403  |  cryoglobulinemia  |  1
C0238124  |  necrotizing fasciitis  |  1
C0162429  |  poor nutrition  |  1
C0035309  |  retinopathy  |  1
C0085253  |  adult-onset still's disease  |  1
C0221757  |  alpha-1 antitrypsin deficiency  |  1
C0039128  |  syphilis  |  1
C0021141  |  syndrome of inappropriate antidiuretic hormone secretion  |  1
C0553662  |  juvenile idiopathic arthritis  |  1
C0014761  |  hemolytic disease of the newborn  |  1
C0022660  |  acute renal failure  |  1
C0020538  |  high blood pressure  |  1
C0002895  |  sickle cell disease  |  1
C0042769  |  viral infections  |  1
C0029089  |  ophthalmoplegia  |  1
C0002871  |  anaemia  |  1
C0027765  |  neurologic disorders  |  1
C0014544  |  epilepsy  |  1
C0026846  |  muscle wasting  |  1
C0019163  |  viral hepatitis b  |  1
C0026764  |  myeloma  |  1
C0030305  |  pancreatitis  |  1
C0025286  |  meningiomas  |  1
C0023530  |  leukopenia  |  1
C0221757  |  alpha 1 antitrypsin deficiency  |  1
C0027765  |  neurological disorders  |  1
C0010054  |  coronary atherosclerosis  |  1
C0745140  |  hyperthyroid  |  1
C0003864  |  arthritis  |  1
C0343386  |  clostridium difficile infection  |  1
C0206698  |  cholangiocellular carcinoma  |  1
C0036202  |  sarcoidosis  |  1
C0008533  |  hemophilia b  |  1
C0008049  |  varicella  |  1
C0242350  |  erectile dysfunction  |  1
C0162568  |  protoporphyria  |  1
C0035435  |  rheumatic diseases  |  1
C0011991  |  diarrhea  |  1
C0008354  |  vibrio cholerae  |  1
C0267211  |  gastric antral vascular ectasia  |  1
C0242379  |  lung cancer  |  1
C0035435  |  rheumatic disease  |  1
C0221757  |  alpha-1-antitrypsin deficiency  |  1
C0679466  |  cognitive deficits  |  1
C0029132  |  optic neuropathy  |  1
C0024115  |  lung disease  |  1
C0023787  |  lipodystrophy  |  1
C0017168  |  esophageal reflux disease  |  1
C0019618  |  histiocytosis  |  1
C0272286  |  immune thrombocytopenia  |  1
C0027947  |  neutropenia  |  1
C0879615  |  stromal tumor  |  1
C0006666  |  calciphylaxis  |  1
C0022104  |  irritable bowel syndrome  |  1
C0030293  |  pancreatic insufficiency  |  1
C0030326  |  panniculitis  |  1
C0021400  |  influenza  |  1
C0022104  |  irritable bowel  |  1
C0017675  |  glossitis  |  1
C0041696  |  major depressive disorder  |  1
C0019196  |  viral hepatitis c  |  1
C0016977  |  gallbladder diseases  |  1
C0026946  |  fungal infection  |  1
C0028326  |  noonan syndrome  |  1
C0271650  |  glucose intolerance  |  1
C0376545  |  hematologic malignancies  |  1
C0020428  |  hyperaldosteronism  |  1
C0043541  |  zygomycosis  |  1
C0031069  |  familial mediterranean fever  |  1
C0019069  |  hemophilia  |  1
C0520459  |  necrotizing enterocolitis  |  1
C1257763  |  overnutrition  |  1
C0027121  |  myositis  |  1
C0017168  |  gastroesophageal reflux disease  |  1
C0042075  |  urological disorders  |  1
C0003507  |  aortic stenosis  |  1
C0034734  |  raynaud's disease  |  1
C0041696  |  major depression  |  1
C0149985  |  secondary syphilis  |  1
C0272170  |  shwachman-diamond syndrome  |  1
C0018916  |  haemangioma  |  1
C1527311  |  brain edema  |  1
C0008350  |  gallstones  |  1
C0085548  |  autosomal recessive polycystic kidney disease  |  1
C0238198  |  gastrointestinal stromal tumor  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:77)
TNF  |  7124  |  CTD_human
NQO1  |  1728  |  CTD_human
ATP8B1  |  5205  |  UniProtKB-KW
SOD1  |  6647  |  CTD_human
CD79B  |  974  |  CTD_human
ABCB11  |  8647  |  UniProtKB-KW;GHR
AMACR  |  23600  |  CTD_human;UniProtKB-KW
NRP1  |  8829  |  CTD_human
TIMP3  |  7078  |  CTD_human
NOTCH2  |  4853  |  GHR
HMOX1  |  3162  |  CTD_human
PRNP  |  5621  |  GHR
CCL2  |  6347  |  CTD_human
MMP9  |  4318  |  CTD_human
BCL2L1  |  598  |  CTD_human
NOS2  |  4843  |  CTD_human
SOCS1  |  8651  |  CTD_human
TJP2  |  9414  |  UniProtKB-KW
COL3A1  |  1281  |  CTD_human
SLC25A13  |  10165  |  UniProtKB-KW
TGM1  |  7051  |  CTD_human
NPC1  |  4864  |  CTD_human
NR1H4  |  9971  |  CTD_human;UniProtKB-KW
CYP7B1  |  9420  |  CTD_human;UniProtKB-KW
ACTA2  |  59  |  CTD_human
JUP  |  3728  |  CTD_human
ATP7B  |  540  |  CTD_human;GHR
MTHFR  |  4524  |  CTD_human
CSF3  |  1440  |  CTD_human
ABCB4  |  5244  |  UniProtKB-KW;GHR
SERPINA1  |  5265  |  CTD_human
HSD3B7  |  80270  |  UniProtKB-KW
CCR2  |  729230  |  CTD_human
CCR1  |  1230  |  CTD_human
CD86  |  942  |  CTD_human
HSPA1A  |  3303  |  CTD_human
JAG1  |  182  |  GHR
GGT1  |  2678  |  CTD_human
TXN  |  7295  |  CTD_human
IL1R2  |  7850  |  CTD_human
CD3D  |  915  |  CTD_human
CCK  |  885  |  CTD_human
SULT1E1  |  6783  |  CTD_human
SC5D  |  6309  |  CTD_human
ITGB6  |  3694  |  CTD_human
ALPL  |  249  |  CTD_human
AHR  |  196  |  CTD_human
ENO3  |  2027  |  CTD_human
RAC1  |  5879  |  CTD_human
DDAH1  |  23576  |  CTD_human
LAT  |  27040  |  CTD_human
HK3  |  3101  |  CTD_human
TYROBP  |  7305  |  CTD_human
IL11  |  3589  |  CTD_human
AKR1D1  |  6718  |  UniProtKB-KW
SCO1  |  6341  |  CTD_human
NFKB1  |  4790  |  CTD_human
ALAD  |  210  |  CTD_human
CRISPLD2  |  83716  |  CTD_human
IL1RAP  |  3556  |  CTD_human
IL9R  |  3581  |  CTD_human
GRK5  |  2869  |  CTD_human
AFP  |  174  |  CTD_human
TREM1  |  54210  |  CTD_human
ASAH2  |  56624  |  CTD_human
RNASE6  |  6039  |  CTD_human
ST8SIA1  |  6489  |  CTD_human
CYP1A2  |  1544  |  CTD_human
ALOX5AP  |  241  |  CTD_human
SRSF5  |  6430  |  CTD_human
SOCS3  |  9021  |  CTD_human
GPT  |  2875  |  CTD_human
GABRR2  |  2570  |  CTD_human
HPGDS  |  27306  |  CTD_human
TM4SF4  |  7104  |  CTD_human
GNG8  |  94235  |  CTD_human
LTB4R  |  1241  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:31)
155  |  ADRB3  |  infer
217  |  ALDH2  |  infer
1586  |  CYP17A1  |  infer
1557  |  CYP2C19  |  infer
1565  |  CYP2D6  |  infer
3119  |  HLA-DQB1  |  infer
3123  |  HLA-DRB1  |  infer
3586  |  IL10  |  infer
4353  |  MPO  |  infer
5696  |  PSMB8  |  infer
5265  |  SERPINA1  |  infer
6891  |  TAP2  |  infer
126  |  ADH1C  |  infer
929  |  CD14  |  infer
1075  |  CTSC  |  infer
22943  |  DKK1  |  infer
1807  |  DPYS  |  infer
2952  |  GSTT1  |  infer
9953  |  HS3ST3B1  |  infer
11253  |  MAN1B1  |  infer
4153  |  MBL2  |  infer
4524  |  MTHFR  |  infer
92345  |  NAF1  |  infer
4886  |  NPY1R  |  infer
4889  |  NPY5R  |  infer
5444  |  PON1  |  infer
5445  |  PON2  |  infer
5446  |  PON3  |  infer
9317  |  PTER  |  infer
6317  |  SERPINB3  |  infer
8403  |  SOX14  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:1342)
100505854  |  APTR  |  DISEASES
282706  |  DAOA-AS1  |  DISEASES
1080  |  CFTR  |  DISEASES
6376  |  CX3CL1  |  DISEASES
920  |  CD4  |  DISEASES
6344  |  SCTR  |  DISEASES
1634  |  DCN  |  DISEASES
10911  |  UTS2  |  DISEASES
84957  |  RELT  |  DISEASES
84699  |  CREB3L3  |  DISEASES
3385  |  ICAM3  |  DISEASES
23152  |  CIC  |  DISEASES
634  |  CEACAM1  |  DISEASES
7132  |  TNFRSF1A  |  DISEASES
2249  |  FGF4  |  DISEASES
6480  |  ST6GAL1  |  DISEASES
3566  |  IL4R  |  DISEASES
9817  |  KEAP1  |  DISEASES
6343  |  SCT  |  DISEASES
30009  |  TBX21  |  DISEASES
1361  |  CPB2  |  DISEASES
2191  |  FAP  |  DISEASES
359  |  AQP2  |  DISEASES
7066  |  THPO  |  DISEASES
350  |  APOH  |  DISEASES
2099  |  ESR1  |  DISEASES
124  |  ADH1A  |  DISEASES
25984  |  KRT23  |  DISEASES
23411  |  SIRT1  |  DISEASES
266  |  AMELY  |  DISEASES
8174  |  MADCAM1  |  DISEASES
3053  |  SERPIND1  |  DISEASES
4282  |  MIF  |  DISEASES
5008  |  OSM  |  DISEASES
11274  |  USP18  |  DISEASES
5594  |  MAPK1  |  DISEASES
6576  |  SLC25A1  |  DISEASES
7494  |  XBP1  |  DISEASES
140564  |  APOBEC3D  |  DISEASES
3162  |  HMOX1  |  DISEASES
80339  |  PNPLA3  |  DISEASES
11035  |  RIPK3  |  DISEASES
1511  |  CTSG  |  DISEASES
3002  |  GZMB  |  DISEASES
1113  |  CHGA  |  DISEASES
6554  |  SLC10A1  |  DISEASES
5106  |  PCK2  |  DISEASES
4792  |  NFKBIA  |  DISEASES
2937  |  GSS  |  DISEASES
5834  |  PYGB  |  DISEASES
28231  |  SLCO4A1  |  DISEASES
128866  |  CHMP4B  |  DISEASES
3929  |  LBP  |  DISEASES
191  |  AHCY  |  DISEASES
5716  |  PSMD10  |  DISEASES
51311  |  TLR8  |  DISEASES
2158  |  F9  |  DISEASES
27344  |  PCSK1N  |  DISEASES
7076  |  TIMP1  |  DISEASES
479  |  ATP12A  |  DISEASES
4313  |  MMP2  |  DISEASES
6367  |  CCL22  |  DISEASES
4210  |  MEFV  |  DISEASES
3163  |  HMOX2  |  DISEASES
10423  |  CDIPT  |  DISEASES
51285  |  RASL12  |  DISEASES
2137  |  EXTL3  |  DISEASES
7038  |  TG  |  DISEASES
1666  |  DECR1  |  DISEASES
5327  |  PLAT  |  DISEASES
83988  |  NCALD  |  DISEASES
2936  |  GSR  |  DISEASES
8797  |  TNFRSF10A  |  DISEASES
54793  |  KCTD9  |  DISEASES
56729  |  RETN  |  DISEASES
2091  |  FBL  |  DISEASES
7040  |  TGFB1  |  DISEASES
10226  |  PLIN3  |  DISEASES
973  |  CD79A  |  DISEASES
1048  |  CEACAM5  |  DISEASES
6822  |  SULT2A1  |  DISEASES
9545  |  RAB3D  |  DISEASES
26291  |  FGF21  |  DISEASES
57817  |  HAMP  |  DISEASES
5444  |  PON1  |  DISEASES
3082  |  HGF  |  DISEASES
10135  |  NAMPT  |  DISEASES
4967  |  OGDH  |  DISEASES
1577  |  CYP3A5  |  DISEASES
7036  |  TFR2  |  DISEASES
5054  |  SERPINE1  |  DISEASES
5919  |  RARRES2  |  DISEASES
727  |  C5  |  DISEASES
7431  |  VIM  |  DISEASES
10105  |  PPIF  |  DISEASES
6348  |  CCL3  |  DISEASES
4353  |  MPO  |  DISEASES
1440  |  CSF3  |  DISEASES
1362  |  CPD  |  DISEASES
1655  |  DDX5  |  DISEASES
6347  |  CCL2  |  DISEASES
6346  |  CCL1  |  DISEASES
6928  |  HNF1B  |  DISEASES
1277  |  COL1A1  |  DISEASES
7448  |  VTN  |  DISEASES
230  |  ALDOC  |  DISEASES
952  |  CD38  |  DISEASES
6783  |  SULT1E1  |  DISEASES
4790  |  NFKB1  |  DISEASES
3558  |  IL2  |  DISEASES
3732  |  CD82  |  DISEASES
3312  |  HSPA8  |  DISEASES
595  |  CCND1  |  DISEASES
345  |  APOC3  |  DISEASES
3587  |  IL10RA  |  DISEASES
8050  |  PDHX  |  DISEASES
84649  |  DGAT2  |  DISEASES
4254  |  KITLG  |  DISEASES
969  |  CD69  |  DISEASES
9761  |  MLEC  |  DISEASES
51561  |  IL23A  |  DISEASES
4055  |  LTBR  |  DISEASES
3458  |  IFNG  |  DISEASES
2597  |  GAPDH  |  DISEASES
7167  |  TPI1  |  DISEASES
55907  |  CMAS  |  DISEASES
57379  |  AICDA  |  DISEASES
3820  |  KLRB1  |  DISEASES
2729  |  GCLC  |  DISEASES
1432  |  MAPK14  |  DISEASES
55856  |  ACOT13  |  DISEASES
135152  |  B3GAT2  |  DISEASES
9841  |  ZBTB24  |  DISEASES
9896  |  FIG4  |  DISEASES
6908  |  TBP  |  DISEASES
55754  |  TMEM30A  |  DISEASES
2690  |  GHR  |  DISEASES
4015  |  LOX  |  DISEASES
3565  |  IL4  |  DISEASES
3567  |  IL5  |  DISEASES
2908  |  NR3C1  |  DISEASES
3273  |  HRG  |  DISEASES
5947  |  RBP1  |  DISEASES
7035  |  TFPI  |  DISEASES
338  |  APOB  |  DISEASES
4358  |  MPV17  |  DISEASES
10297  |  APC2  |  DISEASES
374291  |  NDUFS7  |  DISEASES
3485  |  IGFBP2  |  DISEASES
3554  |  IL1R1  |  DISEASES
5624  |  PROC  |  DISEASES
5657  |  PRTN3  |  DISEASES
2023  |  ENO1  |  DISEASES
6402  |  SELL  |  DISEASES
1509  |  CTSD  |  DISEASES
4317  |  MMP8  |  DISEASES
335  |  APOA1  |  DISEASES
7276  |  TTR  |  DISEASES
9429  |  ABCG2  |  DISEASES
9615  |  GDA  |  DISEASES
7043  |  TGFB3  |  DISEASES
4360  |  MRC1  |  DISEASES
8600  |  TNFSF11  |  DISEASES
1958  |  EGR1  |  DISEASES
847  |  CAT  |  DISEASES
10804  |  GJB6  |  DISEASES
8743  |  TNFSF10  |  DISEASES
4852  |  NPY  |  DISEASES
6718  |  AKR1D1  |  DISEASES
28981  |  IFT81  |  DISEASES
540  |  ATP7B  |  DISEASES
6626  |  SNRPA  |  DISEASES
6615  |  SNAI1  |  DISEASES
5184  |  PEPD  |  DISEASES
1026  |  CDKN1A  |  DISEASES
2806  |  GOT2  |  DISEASES
6555  |  SLC10A2  |  DISEASES
3659  |  IRF1  |  DISEASES
6662  |  SOX9  |  DISEASES
30833  |  NT5C  |  DISEASES
79143  |  MBOAT7  |  DISEASES
57187  |  THOC2  |  DISEASES
718  |  C3  |  DISEASES
10045  |  SH2D3A  |  DISEASES
7389  |  UROD  |  DISEASES
1236  |  CCR7  |  DISEASES
51119  |  SBDS  |  DISEASES
6945  |  MLX  |  DISEASES
7355  |  SLC35A2  |  DISEASES
5199  |  CFP  |  DISEASES
821  |  CANX  |  DISEASES
10365  |  KLF2  |  DISEASES
2671  |  GFER  |  DISEASES
3315  |  HSPB1  |  DISEASES
10875  |  FGL2  |  DISEASES
2678  |  GGT1  |  DISEASES
2952  |  GSTT1  |  DISEASES
22933  |  SIRT2  |  DISEASES
8930  |  MBD4  |  DISEASES
1315  |  COPB1  |  DISEASES
968  |  CD68  |  DISEASES
6351  |  CCL4  |  DISEASES
1215  |  CMA1  |  DISEASES
3630  |  INS  |  DISEASES
64151  |  NCAPG  |  DISEASES
5894  |  RAF1  |  DISEASES
2006  |  ELN  |  DISEASES
5589  |  PRKCSH  |  DISEASES
348  |  APOE  |  DISEASES
55821  |  ALLC  |  DISEASES
59272  |  ACE2  |  DISEASES
1463  |  NCAN  |  DISEASES
684  |  BST2  |  DISEASES
2056  |  EPO  |  DISEASES
9518  |  GDF15  |  DISEASES
3727  |  JUND  |  DISEASES
1571  |  CYP2E1  |  DISEASES
445  |  ASS1  |  DISEASES
25926  |  NOL11  |  DISEASES
10343  |  PKDREJ  |  DISEASES
9104  |  RGN  |  DISEASES
2161  |  F12  |  DISEASES
9945  |  GFPT2  |  DISEASES
2538  |  G6PC  |  DISEASES
50617  |  ATP6V0A4  |  DISEASES
8431  |  NR0B2  |  DISEASES
3958  |  LGALS3  |  DISEASES
3337  |  DNAJB1  |  DISEASES
6382  |  SDC1  |  DISEASES
6737  |  TRIM21  |  DISEASES
23225  |  NUP210  |  DISEASES
5791  |  PTPRE  |  DISEASES
182  |  JAG1  |  DISEASES
1401  |  CRP  |  DISEASES
325  |  APCS  |  DISEASES
6341  |  SCO1  |  DISEASES
1116  |  CHI3L1  |  DISEASES
3845  |  KRAS  |  DISEASES
759  |  CA1  |  DISEASES
10894  |  LYVE1  |  DISEASES
1965  |  EIF2S1  |  DISEASES
9695  |  EDEM1  |  DISEASES
10752  |  CHL1  |  DISEASES
4853  |  NOTCH2  |  DISEASES
23175  |  LPIN1  |  DISEASES
10468  |  FST  |  DISEASES
10599  |  SLCO1B1  |  DISEASES
2694  |  GIF  |  DISEASES
187  |  APLNR  |  DISEASES
6947  |  TCN1  |  DISEASES
6927  |  HNF1A  |  DISEASES
8638  |  OASL  |  DISEASES
29969  |  MDFIC  |  DISEASES
4907  |  NT5E  |  DISEASES
1019  |  CDK4  |  DISEASES
10024  |  TROAP  |  DISEASES
1593  |  CYP27A1  |  DISEASES
3569  |  IL6  |  DISEASES
10241  |  CALCOCO2  |  DISEASES
3557  |  IL1RN  |  DISEASES
26525  |  IL36RN  |  DISEASES
84317  |  CCDC115  |  DISEASES
9394  |  HS6ST1  |  DISEASES
570  |  BAAT  |  DISEASES
5168  |  ENPP2  |  DISEASES
3442  |  IFNA5  |  DISEASES
8737  |  RIPK1  |  DISEASES
7097  |  TLR2  |  DISEASES
7274  |  TTPA  |  DISEASES
4316  |  MMP7  |  DISEASES
4322  |  MMP13  |  DISEASES
7057  |  THBS1  |  DISEASES
3795  |  KHK  |  DISEASES
64240  |  ABCG5  |  DISEASES
1559  |  CYP2C9  |  DISEASES
2660  |  MSTN  |  DISEASES
6741  |  SSB  |  DISEASES
9360  |  PPIG  |  DISEASES
30061  |  SLC40A1  |  DISEASES
10063  |  COX17  |  DISEASES
28234  |  SLCO1B3  |  DISEASES
4659  |  PPP1R12A  |  DISEASES
4069  |  LYZ  |  DISEASES
7450  |  VWF  |  DISEASES
10162  |  LPCAT3  |  DISEASES
949  |  SCARB1  |  DISEASES
6532  |  SLC6A4  |  DISEASES
217  |  ALDH2  |  DISEASES
2184  |  FAH  |  DISEASES
999  |  CDH1  |  DISEASES
5159  |  PDGFRB  |  DISEASES
58517  |  RBM25  |  DISEASES
23531  |  MMD  |  DISEASES
4481  |  MSR1  |  DISEASES
9172  |  MYOM2  |  DISEASES
54947  |  LPCAT2  |  DISEASES
4092  |  SMAD7  |  DISEASES
4087  |  SMAD2  |  DISEASES
4591  |  TRIM37  |  DISEASES
3595  |  IL12RB2  |  DISEASES
3674  |  ITGA2B  |  DISEASES
6521  |  SLC4A1  |  DISEASES
6558  |  SLC12A2  |  DISEASES
79792  |  GSDMD  |  DISEASES
495  |  ATP4A  |  DISEASES
3249  |  HPN  |  DISEASES
5465  |  PPARA  |  DISEASES
7077  |  TIMP2  |  DISEASES
3959  |  LGALS3BP  |  DISEASES
671  |  BPI  |  DISEASES
25939  |  SAMHD1  |  DISEASES
91039  |  DPP9  |  DISEASES
5595  |  MAPK3  |  DISEASES
10133  |  OPTN  |  DISEASES
22858  |  ICK  |  DISEASES
10998  |  SLC27A5  |  DISEASES
23523  |  CABIN1  |  DISEASES
2033  |  EP300  |  DISEASES
4924  |  NUCB1  |  DISEASES
50507  |  NOX4  |  DISEASES
7299  |  TYR  |  DISEASES
3552  |  IL1A  |  DISEASES
3553  |  IL1B  |  DISEASES
645  |  BLVRB  |  DISEASES
23476  |  BRD4  |  DISEASES
55717  |  WDR11  |  DISEASES
1991  |  ELANE  |  DISEASES
64135  |  IFIH1  |  DISEASES
975  |  CD81  |  DISEASES
6403  |  SELP  |  DISEASES
9410  |  SNRNP40  |  DISEASES
4072  |  EPCAM  |  DISEASES
8647  |  ABCB11  |  DISEASES
10578  |  GNLY  |  DISEASES
3791  |  KDR  |  DISEASES
943  |  TNFRSF8  |  DISEASES
3931  |  LCAT  |  DISEASES
3299  |  HSF4  |  DISEASES
1716  |  DGUOK  |  DISEASES
4811  |  NID1  |  DISEASES
941  |  CD80  |  DISEASES
590  |  BCHE  |  DISEASES
374  |  AREG  |  DISEASES
59067  |  IL21  |  DISEASES
2247  |  FGF2  |  DISEASES
3589  |  IL11  |  DISEASES
1356  |  CP  |  DISEASES
6774  |  STAT3  |  DISEASES
80725  |  SRCIN1  |  DISEASES
3818  |  KLKB1  |  DISEASES
5443  |  POMC  |  DISEASES
8626  |  TP63  |  DISEASES
7297  |  TYK2  |  DISEASES
3383  |  ICAM1  |  DISEASES
10891  |  PPARGC1A  |  DISEASES
54464  |  XRN1  |  DISEASES
3827  |  KNG1  |  DISEASES
64083  |  GOLPH3  |  DISEASES
1950  |  EGF  |  DISEASES
10058  |  ABCB6  |  DISEASES
1390  |  CREM  |  DISEASES
23534  |  TNPO3  |  DISEASES
127  |  ADH4  |  DISEASES
4547  |  MTTP  |  DISEASES
644  |  BLVRA  |  DISEASES
5446  |  PON3  |  DISEASES
1374  |  CPT1A  |  DISEASES
51083  |  GAL  |  DISEASES
5244  |  ABCB4  |  DISEASES
5243  |  ABCB1  |  DISEASES
63898  |  SH2D4A  |  DISEASES
51608  |  GET4  |  DISEASES
5286  |  PIK3C2A  |  DISEASES
3263  |  HPX  |  DISEASES
3700  |  ITIH4  |  DISEASES
6425  |  SFRP5  |  DISEASES
56938  |  ARNTL2  |  DISEASES
4704  |  NDUFA9  |  DISEASES
939  |  CD27  |  DISEASES
4060  |  LUM  |  DISEASES
7112  |  TMPO  |  DISEASES
1017  |  CDK2  |  DISEASES
51411  |  BIN2  |  DISEASES
6751  |  SSTR1  |  DISEASES
6652  |  SORD  |  DISEASES
3480  |  IGF1R  |  DISEASES
5371  |  PML  |  DISEASES
5428  |  POLG  |  DISEASES
5045  |  FURIN  |  DISEASES
3687  |  ITGAX  |  DISEASES
54957  |  TXNL4B  |  DISEASES
1000  |  CDH2  |  DISEASES
4864  |  NPC1  |  DISEASES
409  |  ARRB2  |  DISEASES
432  |  ASGR1  |  DISEASES
7157  |  TP53  |  DISEASES
2064  |  ERBB2  |  DISEASES
5409  |  PNMT  |  DISEASES
54858  |  PGPEP1  |  DISEASES
3454  |  IFNAR1  |  DISEASES
150094  |  SIK1  |  DISEASES
207  |  AKT1  |  DISEASES
126147  |  NTN5  |  DISEASES
6531  |  SLC6A3  |  DISEASES
58985  |  IL22RA1  |  DISEASES
3756  |  KCNH1  |  DISEASES
3930  |  LBR  |  DISEASES
2052  |  EPHX1  |  DISEASES
5972  |  REN  |  DISEASES
64241  |  ABCG8  |  DISEASES
805  |  CALM2  |  DISEASES
27233  |  SULT1C4  |  DISEASES
185  |  AGTR1  |  DISEASES
2495  |  FTH1  |  DISEASES
9515  |  STXBP5L  |  DISEASES
2169  |  FABP2  |  DISEASES
3001  |  GZMA  |  DISEASES
635  |  BHMT  |  DISEASES
167410  |  LIX1  |  DISEASES
3950  |  LECT2  |  DISEASES
3578  |  IL9  |  DISEASES
51302  |  CYP39A1  |  DISEASES
134864  |  TAAR1  |  DISEASES
1956  |  EGFR  |  DISEASES
3484  |  IGFBP1  |  DISEASES
6872  |  TAF1  |  DISEASES
92129  |  RIPPLY1  |  DISEASES
55909  |  BIN3  |  DISEASES
8795  |  TNFRSF10B  |  DISEASES
123  |  PLIN2  |  DISEASES
3439  |  IFNA1  |  DISEASES
3934  |  LCN2  |  DISEASES
4851  |  NOTCH1  |  DISEASES
133  |  ADM  |  DISEASES
3145  |  HMBS  |  DISEASES
9415  |  FADS2  |  DISEASES
149986  |  LSM14B  |  DISEASES
1489  |  CTF1  |  DISEASES
1737  |  DLAT  |  DISEASES
3606  |  IL18  |  DISEASES
5805  |  PTS  |  DISEASES
7082  |  TJP1  |  DISEASES
5741  |  PTH  |  DISEASES
3087  |  HHEX  |  DISEASES
1360  |  CPB1  |  DISEASES
3694  |  ITGB6  |  DISEASES
23250  |  ATP11A  |  DISEASES
925  |  CD8A  |  DISEASES
5205  |  ATP8B1  |  DISEASES
6317  |  SERPINB3  |  DISEASES
7070  |  THY1  |  DISEASES
7345  |  UCHL1  |  DISEASES
89780  |  WNT3A  |  DISEASES
136991  |  ASZ1  |  DISEASES
118611  |  C10orf90  |  DISEASES
4645  |  MYO5B  |  DISEASES
8714  |  ABCC3  |  DISEASES
760  |  CA2  |  DISEASES
761  |  CA3  |  DISEASES
231  |  AKR1B1  |  DISEASES
9601  |  PDIA4  |  DISEASES
1436  |  CSF1R  |  DISEASES
10  |  NAT2  |  DISEASES
27163  |  NAAA  |  DISEASES
10563  |  CXCL13  |  DISEASES
7547  |  ZIC3  |  DISEASES
6750  |  SST  |  DISEASES
5468  |  PPARG  |  DISEASES
3156  |  HMGCR  |  DISEASES
3815  |  KIT  |  DISEASES
6296  |  ACSM3  |  DISEASES
909  |  CD1A  |  DISEASES
653361  |  NCF1  |  DISEASES
29881  |  NPC1L1  |  DISEASES
11309  |  SLCO2B1  |  DISEASES
23516  |  SLC39A14  |  DISEASES
3588  |  IL10RB  |  DISEASES
539  |  ATP5O  |  DISEASES
55687  |  TRMU  |  DISEASES
1636  |  ACE  |  DISEASES
808  |  CALM3  |  DISEASES
326  |  AIRE  |  DISEASES
10841  |  FTCD  |  DISEASES
6285  |  S100B  |  DISEASES
2220  |  FCN2  |  DISEASES
9437  |  NCR1  |  DISEASES
643  |  CXCR5  |  DISEASES
729230  |  CCR2  |  DISEASES
1234  |  CCR5  |  DISEASES
2264  |  FGFR4  |  DISEASES
3046  |  HBE1  |  DISEASES
114757  |  CYGB  |  DISEASES
6352  |  CCL5  |  DISEASES
6359  |  CCL15  |  DISEASES
3856  |  KRT8  |  DISEASES
6777  |  STAT5B  |  DISEASES
10197  |  PSME3  |  DISEASES
1990  |  CELA1  |  DISEASES
58191  |  CXCL16  |  DISEASES
9965  |  FGF19  |  DISEASES
178  |  AGL  |  DISEASES
7412  |  VCAM1  |  DISEASES
2215  |  FCGR3B  |  DISEASES
5966  |  REL  |  DISEASES
27306  |  HPGDS  |  DISEASES
10461  |  MERTK  |  DISEASES
4880  |  NPPC  |  DISEASES
248  |  ALPI  |  DISEASES
9076  |  CLDN1  |  DISEASES
3577  |  CXCR1  |  DISEASES
5798  |  PTPRN  |  DISEASES
3549  |  IHH  |  DISEASES
5274  |  SERPINI1  |  DISEASES
2168  |  FABP1  |  DISEASES
213  |  ALB  |  DISEASES
285368  |  PRRT3  |  DISEASES
6374  |  CXCL5  |  DISEASES
5473  |  PPBP  |  DISEASES
5196  |  PF4  |  DISEASES
7047  |  TGM4  |  DISEASES
1230  |  CCR1  |  DISEASES
5648  |  MASP1  |  DISEASES
128  |  ADH5  |  DISEASES
327  |  APEH  |  DISEASES
84315  |  MON1A  |  DISEASES
308  |  ANXA5  |  DISEASES
3600  |  IL15  |  DISEASES
3673  |  ITGA2  |  DISEASES
51151  |  SLC45A2  |  DISEASES
4724  |  NDUFS4  |  DISEASES
6690  |  SPINK1  |  DISEASES
9607  |  CARTPT  |  DISEASES
7098  |  TLR3  |  DISEASES
27242  |  TNFRSF21  |  DISEASES
3562  |  IL3  |  DISEASES
1437  |  CSF2  |  DISEASES
168667  |  BMPER  |  DISEASES
6469  |  SHH  |  DISEASES
1278  |  COL1A2  |  DISEASES
4982  |  TNFRSF11B  |  DISEASES
4846  |  NOS3  |  DISEASES
80270  |  HSD3B7  |  DISEASES
7373  |  COL14A1  |  DISEASES
139324  |  HDX  |  DISEASES
360  |  AQP3  |  DISEASES
10935  |  PRDX3  |  DISEASES
5267  |  SERPINA4  |  DISEASES
3429  |  IFI27  |  DISEASES
3990  |  LIPC  |  DISEASES
3611  |  ILK  |  DISEASES
5896  |  RAG1  |  DISEASES
5055  |  SERPINB2  |  DISEASES
79053  |  ALG8  |  DISEASES
7184  |  HSP90B1  |  DISEASES
4314  |  MMP3  |  DISEASES
5479  |  PPIB  |  DISEASES
5346  |  PLIN1  |  DISEASES
6778  |  STAT6  |  DISEASES
26585  |  GREM1  |  DISEASES
5245  |  PHB  |  DISEASES
90678  |  LRSAM1  |  DISEASES
64127  |  NOD2  |  DISEASES
10308  |  ZNF267  |  DISEASES
1548  |  CYP2A6  |  DISEASES
1549  |  CYP2A7  |  DISEASES
124935  |  SLC43A2  |  DISEASES
1581  |  CYP7A1  |  DISEASES
8772  |  FADD  |  DISEASES
116071  |  BATF2  |  DISEASES
3960  |  LGALS4  |  DISEASES
53354  |  PANK1  |  DISEASES
5617  |  PRL  |  DISEASES
6356  |  CCL11  |  DISEASES
51523  |  CXXC5  |  DISEASES
598  |  BCL2L1  |  DISEASES
64581  |  CLEC7A  |  DISEASES
189  |  AGXT  |  DISEASES
3175  |  ONECUT1  |  DISEASES
3479  |  IGF1  |  DISEASES
2990  |  GUSB  |  DISEASES
3308  |  HSPA4  |  DISEASES
10972  |  TMED10  |  DISEASES
4144  |  MAT2A  |  DISEASES
54578  |  UGT1A6  |  DISEASES
255738  |  PCSK9  |  DISEASES
59350  |  RXFP1  |  DISEASES
3688  |  ITGB1  |  DISEASES
8988  |  HSPB3  |  DISEASES
7200  |  TRH  |  DISEASES
29  |  ABR  |  DISEASES
1493  |  CTLA4  |  DISEASES
3171  |  FOXA3  |  DISEASES
3094  |  HINT1  |  DISEASES
5068  |  REG3A  |  DISEASES
10663  |  CXCR6  |  DISEASES
171558  |  PTCRA  |  DISEASES
7064  |  THOP1  |  DISEASES
2194  |  FASN  |  DISEASES
79071  |  ELOVL6  |  DISEASES
375611  |  SLC26A5  |  DISEASES
54658  |  UGT1A1  |  DISEASES
3667  |  IRS1  |  DISEASES
3596  |  IL13  |  DISEASES
7363  |  UGT2B4  |  DISEASES
1051  |  CEBPB  |  DISEASES
8862  |  APLN  |  DISEASES
3627  |  CXCL10  |  DISEASES
7399  |  USH2A  |  DISEASES
6579  |  SLCO1A2  |  DISEASES
5066  |  PAM  |  DISEASES
3575  |  IL7R  |  DISEASES
2353  |  FOS  |  DISEASES
149603  |  RNF187  |  DISEASES
4968  |  OGG1  |  DISEASES
3669  |  ISG20  |  DISEASES
125  |  ADH1B  |  DISEASES
56246  |  MRAP  |  DISEASES
6373  |  CXCL11  |  DISEASES
646  |  BNC1  |  DISEASES
435  |  ASL  |  DISEASES
9451  |  EIF2AK3  |  DISEASES
54205  |  CYCS  |  DISEASES
27087  |  B3GAT1  |  DISEASES
2752  |  GLUL  |  DISEASES
4323  |  MMP14  |  DISEASES
150684  |  COMMD1  |  DISEASES
197259  |  MLKL  |  DISEASES
64081  |  PBLD  |  DISEASES
2147  |  F2  |  DISEASES
9940  |  DLEC1  |  DISEASES
5897  |  RAG2  |  DISEASES
3626  |  INHBC  |  DISEASES
5644  |  PRSS1  |  DISEASES
344561  |  GPR148  |  DISEASES
5340  |  PLG  |  DISEASES
211  |  ALAS1  |  DISEASES
1212  |  CLTB  |  DISEASES
125988  |  C19orf70  |  DISEASES
7015  |  TERT  |  DISEASES
4023  |  LPL  |  DISEASES
3265  |  HRAS  |  DISEASES
6868  |  ADAM17  |  DISEASES
947  |  CD34  |  DISEASES
3661  |  IRF3  |  DISEASES
22885  |  ABLIM3  |  DISEASES
2829  |  XCR1  |  DISEASES
27243  |  CHMP2A  |  DISEASES
27257  |  LSM1  |  DISEASES
225  |  ABCD2  |  DISEASES
9420  |  CYP7B1  |  DISEASES
2286  |  FKBP2  |  DISEASES
11037  |  STON1  |  DISEASES
836  |  CASP3  |  DISEASES
1579  |  CYP4A11  |  DISEASES
358  |  AQP1  |  DISEASES
148229  |  ATP8B3  |  DISEASES
118430  |  MUCL1  |  DISEASES
2944  |  GSTM1  |  DISEASES
22949  |  PTGR1  |  DISEASES
84868  |  HAVCR2  |  DISEASES
7351  |  UCP2  |  DISEASES
8639  |  AOC3  |  DISEASES
134083  |  OR2Y1  |  DISEASES
8837  |  CFLAR  |  DISEASES
80194  |  TMEM134  |  DISEASES
3952  |  LEP  |  DISEASES
23166  |  STAB1  |  DISEASES
3172  |  HNF4A  |  DISEASES
11322  |  TMC6  |  DISEASES
5257  |  PHKB  |  DISEASES
51593  |  SRRT  |  DISEASES
285  |  ANGPT2  |  DISEASES
9153  |  SLC28A2  |  DISEASES
1909  |  EDNRA  |  DISEASES
1191  |  CLU  |  DISEASES
30835  |  CD209  |  DISEASES
6773  |  STAT2  |  DISEASES
3170  |  FOXA2  |  DISEASES
10332  |  CLEC4M  |  DISEASES
8560  |  DEGS1  |  DISEASES
65987  |  KCTD14  |  DISEASES
10170  |  DHRS9  |  DISEASES
3291  |  HSD11B2  |  DISEASES
475  |  ATOX1  |  DISEASES
4233  |  MET  |  DISEASES
8824  |  CES2  |  DISEASES
9475  |  ROCK2  |  DISEASES
4684  |  NCAM1  |  DISEASES
23621  |  BACE1  |  DISEASES
7173  |  TPO  |  DISEASES
1582  |  CYP8B1  |  DISEASES
79901  |  CYBRD1  |  DISEASES
26973  |  CHORDC1  |  DISEASES
84967  |  LSM10  |  DISEASES
29851  |  ICOS  |  DISEASES
3579  |  CXCR2  |  DISEASES
63951  |  DMRTA1  |  DISEASES
1728  |  NQO1  |  DISEASES
80381  |  CD276  |  DISEASES
8289  |  ARID1A  |  DISEASES
9370  |  ADIPOQ  |  DISEASES
811  |  CALR  |  DISEASES
51085  |  MLXIPL  |  DISEASES
23765  |  IL17RA  |  DISEASES
6863  |  TAC1  |  DISEASES
25898  |  RCHY1  |  DISEASES
6888  |  TALDO1  |  DISEASES
4018  |  LPA  |  DISEASES
51582  |  AZIN1  |  DISEASES
3615  |  IMPDH2  |  DISEASES
10611  |  PDLIM5  |  DISEASES
6014  |  RIT2  |  DISEASES
5345  |  SERPINF2  |  DISEASES
6181  |  RPLP2  |  DISEASES
3039  |  HBA1  |  DISEASES
3157  |  HMGCS1  |  DISEASES
4312  |  MMP1  |  DISEASES
55  |  ACPP  |  DISEASES
27036  |  SIGLEC7  |  DISEASES
8706  |  B3GALNT1  |  DISEASES
2837  |  UTS2R  |  DISEASES
2  |  A2M  |  DISEASES
3309  |  HSPA5  |  DISEASES
56252  |  YLPM1  |  DISEASES
2314  |  FLII  |  DISEASES
1555  |  CYP2B6  |  DISEASES
9235  |  IL32  |  DISEASES
6794  |  STK11  |  DISEASES
147138  |  TMC8  |  DISEASES
9159  |  PCSK7  |  DISEASES
9622  |  KLK4  |  DISEASES
117584  |  RFFL  |  DISEASES
51330  |  TNFRSF12A  |  DISEASES
9015  |  TAF1A  |  DISEASES
4843  |  NOS2  |  DISEASES
9582  |  APOBEC3B  |  DISEASES
1435  |  CSF1  |  DISEASES
339390  |  CLEC4G  |  DISEASES
26276  |  VPS33B  |  DISEASES
5034  |  P4HB  |  DISEASES
9241  |  NOG  |  DISEASES
1789  |  DNMT3B  |  DISEASES
9074  |  CLDN6  |  DISEASES
147719  |  LYPD4  |  DISEASES
706  |  TSPO  |  DISEASES
3855  |  KRT7  |  DISEASES
6906  |  SERPINA7  |  DISEASES
50616  |  IL22  |  DISEASES
3665  |  IRF7  |  DISEASES
8651  |  SOCS1  |  DISEASES
842  |  CASP9  |  DISEASES
9021  |  SOCS3  |  DISEASES
5155  |  PDGFB  |  DISEASES
3953  |  LEPR  |  DISEASES
493753  |  COA5  |  DISEASES
8519  |  IFITM1  |  DISEASES
2520  |  GAST  |  DISEASES
54328  |  GPR173  |  DISEASES
6401  |  SELE  |  DISEASES
796  |  CALCA  |  DISEASES
64782  |  AEN  |  DISEASES
942  |  CD86  |  DISEASES
8694  |  DGAT1  |  DISEASES
9145  |  SYNGR1  |  DISEASES
212  |  ALAS2  |  DISEASES
1553  |  CYP2A13  |  DISEASES
286410  |  ATP11C  |  DISEASES
256933  |  NPB  |  DISEASES
4088  |  SMAD3  |  DISEASES
5104  |  SERPINA5  |  DISEASES
3916  |  LAMP1  |  DISEASES
682  |  BSG  |  DISEASES
151888  |  BTLA  |  DISEASES
3043  |  HBB  |  DISEASES
2152  |  F3  |  DISEASES
220001  |  VWCE  |  DISEASES
120227  |  CYP2R1  |  DISEASES
5133  |  PDCD1  |  DISEASES
51738  |  GHRL  |  DISEASES
3320  |  HSP90AA1  |  DISEASES
123264  |  SLC51B  |  DISEASES
2938  |  GSTA1  |  DISEASES
885  |  CCK  |  DISEASES
8856  |  NR1I2  |  DISEASES
468  |  ATF4  |  DISEASES
2266  |  FGG  |  DISEASES
148738  |  HFE2  |  DISEASES
1908  |  EDN3  |  DISEASES
3988  |  LIPA  |  DISEASES
114548  |  NLRP3  |  DISEASES
112744  |  IL17F  |  DISEASES
1551  |  CYP3A7  |  DISEASES
4842  |  NOS1  |  DISEASES
84324  |  SARNP  |  DISEASES
57104  |  PNPLA2  |  DISEASES
3932  |  LCK  |  DISEASES
57142  |  RTN4  |  DISEASES
1576  |  CYP3A4  |  DISEASES
3363  |  HTR7  |  DISEASES
3091  |  HIF1A  |  DISEASES
554  |  AVPR2  |  DISEASES
3824  |  KLRD1  |  DISEASES
23436  |  CELA3B  |  DISEASES
3141  |  HLCS  |  DISEASES
23583  |  SMUG1  |  DISEASES
7360  |  UGP2  |  DISEASES
3572  |  IL6ST  |  DISEASES
2686  |  GGT7  |  DISEASES
3266  |  ERAS  |  DISEASES
857  |  CAV1  |  DISEASES
54878  |  DPP8  |  DISEASES
5329  |  PLAUR  |  DISEASES
3117  |  HLA-DQA1  |  DISEASES
8835  |  SOCS2  |  DISEASES
2309  |  FOXO3  |  DISEASES
200810  |  ALG1L  |  DISEASES
3329  |  HSPD1  |  DISEASES
7100  |  TLR5  |  DISEASES
8788  |  DLK1  |  DISEASES
6609  |  SMPD1  |  DISEASES
23193  |  GANAB  |  DISEASES
113675  |  SDSL  |  DISEASES
6776  |  STAT5A  |  DISEASES
8717  |  TRADD  |  DISEASES
4306  |  NR3C2  |  DISEASES
54681  |  P4HTM  |  DISEASES
4089  |  SMAD4  |  DISEASES
1528  |  CYB5A  |  DISEASES
51094  |  ADIPOR1  |  DISEASES
1544  |  CYP1A2  |  DISEASES
9588  |  PRDX6  |  DISEASES
1508  |  CTSB  |  DISEASES
6692  |  SPINT1  |  DISEASES
145264  |  SERPINA12  |  DISEASES
259197  |  NCR3  |  DISEASES
3804  |  KIR2DL3  |  DISEASES
4939  |  OAS2  |  DISEASES
2537  |  IFI6  |  DISEASES
921  |  CD5  |  DISEASES
866  |  SERPINA6  |  DISEASES
6672  |  SP100  |  DISEASES
3146  |  HMGB1  |  DISEASES
3716  |  JAK1  |  DISEASES
54575  |  UGT1A10  |  DISEASES
2100  |  ESR2  |  DISEASES
3455  |  IFNAR2  |  DISEASES
127665  |  ZNF648  |  DISEASES
3605  |  IL17A  |  DISEASES
8720  |  MBTPS1  |  DISEASES
285193  |  DUSP28  |  DISEASES
1499  |  CTNNB1  |  DISEASES
875  |  CBS  |  DISEASES
31  |  ACACA  |  DISEASES
26762  |  HAVCR1  |  DISEASES
3516  |  RBPJ  |  DISEASES
84706  |  GPT2  |  DISEASES
25813  |  SAMM50  |  DISEASES
3767  |  KCNJ11  |  DISEASES
1861  |  TOR1A  |  DISEASES
538  |  ATP7A  |  DISEASES
1811  |  SLC26A3  |  DISEASES
302  |  ANXA2  |  DISEASES
6275  |  S100A4  |  DISEASES
23481  |  PES1  |  DISEASES
54600  |  UGT1A9  |  DISEASES
2335  |  FN1  |  DISEASES
2873  |  GPS1  |  DISEASES
100506658  |  OCLN  |  DISEASES
3792  |  KEL  |  DISEASES
331  |  XIAP  |  DISEASES
8764  |  TNFRSF14  |  DISEASES
355  |  FAS  |  DISEASES
5265  |  SERPINA1  |  DISEASES
6720  |  SREBF1  |  DISEASES
2074  |  ERCC6  |  DISEASES
3240  |  HP  |  DISEASES
6898  |  TAT  |  DISEASES
51155  |  HN1  |  DISEASES
79876  |  UBA5  |  DISEASES
6288  |  SAA1  |  DISEASES
2224  |  FDPS  |  DISEASES
4100  |  MAGEA1  |  DISEASES
3683  |  ITGAL  |  DISEASES
246778  |  IL27  |  DISEASES
3482  |  IGF2R  |  DISEASES
801  |  CALM1  |  DISEASES
11186  |  RASSF1  |  DISEASES
79602  |  ADIPOR2  |  DISEASES
3663  |  IRF5  |  DISEASES
60  |  ACTB  |  DISEASES
10803  |  CCR9  |  DISEASES
5169  |  ENPP3  |  DISEASES
871  |  SERPINH1  |  DISEASES
26136  |  TES  |  DISEASES
6714  |  SRC  |  DISEASES
51643  |  TMBIM4  |  DISEASES
1524  |  CX3CR1  |  DISEASES
1969  |  EPHA2  |  DISEASES
6775  |  STAT4  |  DISEASES
841  |  CASP8  |  DISEASES
2996  |  GYPE  |  DISEASES
9652  |  TTC37  |  DISEASES
112476  |  PRRT2  |  DISEASES
6364  |  CCL20  |  DISEASES
92689  |  FAM114A1  |  DISEASES
23644  |  EDC4  |  DISEASES
7048  |  TGFBR2  |  DISEASES
3821  |  KLRC1  |  DISEASES
9332  |  CD163  |  DISEASES
617  |  BCS1L  |  DISEASES
4151  |  MB  |  DISEASES
79892  |  MCMBP  |  DISEASES
3123  |  HLA-DRB1  |  DISEASES
79947  |  DHDDS  |  DISEASES
7037  |  TFRC  |  DISEASES
2157  |  F8  |  DISEASES
4478  |  MSN  |  DISEASES
3135  |  HLA-G  |  DISEASES
1366  |  CLDN7  |  DISEASES
5599  |  MAPK8  |  DISEASES
4311  |  MME  |  DISEASES
1066  |  CES1  |  DISEASES
1803  |  DPP4  |  DISEASES
58506  |  SCAF1  |  DISEASES
1565  |  CYP2D6  |  DISEASES
54106  |  TLR9  |  DISEASES
26580  |  BSCL2  |  DISEASES
6533  |  SLC6A6  |  DISEASES
2673  |  GFPT1  |  DISEASES
6772  |  STAT1  |  DISEASES
10367  |  MICU1  |  DISEASES
6721  |  SREBF2  |  DISEASES
4512  |  MT-CO1  |  DISEASES
2475  |  MTOR  |  DISEASES
5742  |  PTGS1  |  DISEASES
10724  |  MGEA5  |  DISEASES
2705  |  GJB1  |  DISEASES
4283  |  CXCL9  |  DISEASES
7096  |  TLR1  |  DISEASES
4514  |  MT-CO3  |  DISEASES
3880  |  KRT19  |  DISEASES
8678  |  BECN1  |  DISEASES
23038  |  WDTC1  |  DISEASES
7052  |  TGM2  |  DISEASES
27350  |  APOBEC3C  |  DISEASES
84284  |  NTPCR  |  DISEASES
8443  |  GNPAT  |  DISEASES
183  |  AGT  |  DISEASES
22796  |  COG2  |  DISEASES
58  |  ACTA1  |  DISEASES
28514  |  DLL1  |  DISEASES
116841  |  SNAP47  |  DISEASES
142  |  PARP1  |  DISEASES
55532  |  SLC30A10  |  DISEASES
7042  |  TGFB2  |  DISEASES
1063  |  CENPF  |  DISEASES
3664  |  IRF6  |  DISEASES
1378  |  CR1  |  DISEASES
6993  |  DYNLT1  |  DISEASES
7432  |  VIP  |  DISEASES
59349  |  KLHL12  |  DISEASES
2494  |  NR5A2  |  DISEASES
5788  |  PTPRC  |  DISEASES
3075  |  CFH  |  DISEASES
6738  |  TROVE2  |  DISEASES
5743  |  PTGS2  |  DISEASES
1660  |  DHX9  |  DISEASES
6041  |  RNASEL  |  DISEASES
462  |  SERPINC1  |  DISEASES
356  |  FASLG  |  DISEASES
2153  |  F5  |  DISEASES
22926  |  ATF6  |  DISEASES
2214  |  FCGR3A  |  DISEASES
1490  |  CTGF  |  DISEASES
9970  |  NR1I3  |  DISEASES
336  |  APOA2  |  DISEASES
4720  |  NDUFS2  |  DISEASES
51744  |  CD244  |  DISEASES
1314  |  COPA  |  DISEASES
383  |  ARG1  |  DISEASES
9447  |  AIM2  |  DISEASES
911  |  CD1C  |  DISEASES
912  |  CD1D  |  DISEASES
922  |  CD5L  |  DISEASES
632  |  BGLAP  |  DISEASES
4582  |  MUC1  |  DISEASES
55974  |  SLC50A1  |  DISEASES
103  |  ADAR  |  DISEASES
3570  |  IL6R  |  DISEASES
57198  |  ATP8B2  |  DISEASES
1892  |  ECHS1  |  DISEASES
119467  |  CLRN3  |  DISEASES
6280  |  S100A9  |  DISEASES
284486  |  THEM5  |  DISEASES
4942  |  OAT  |  DISEASES
79626  |  TNFAIP8L2  |  DISEASES
246269  |  LACE1  |  DISEASES
5550  |  PREP  |  DISEASES
914  |  CD2  |  DISEASES
965  |  CD58  |  DISEASES
1268  |  CNR1  |  DISEASES
4893  |  NRAS  |  DISEASES
8517  |  IKBKG  |  DISEASES
2316  |  FLNA  |  DISEASES
8729  |  GBF1  |  DISEASES
8771  |  TNFRSF6B  |  DISEASES
1629  |  DBT  |  DISEASES
2730  |  GCLM  |  DISEASES
6319  |  SCD  |  DISEASES
1244  |  ABCC2  |  DISEASES
4923  |  NTSR1  |  DISEASES
2805  |  GOT1  |  DISEASES
959  |  CD40LG  |  DISEASES
55361  |  PI4K2A  |  DISEASES
10964  |  IFI44L  |  DISEASES
1491  |  CTH  |  DISEASES
2941  |  GSTA4  |  DISEASES
5314  |  PKHD1  |  DISEASES
1791  |  DNTT  |  DISEASES
953  |  ENTPD1  |  DISEASES
3725  |  JUN  |  DISEASES
1558  |  CYP2C8  |  DISEASES
1557  |  CYP2C19  |  DISEASES
5950  |  RBP4  |  DISEASES
55268  |  ECHDC2  |  DISEASES
11253  |  MAN1B1  |  DISEASES
2030  |  SLC29A1  |  DISEASES
64170  |  CARD9  |  DISEASES
3434  |  IFIT1  |  DISEASES
3437  |  IFIT3  |  DISEASES
11093  |  ADAMTS13  |  DISEASES
5728  |  PTEN  |  DISEASES
7422  |  VEGFA  |  DISEASES
4143  |  MAT1A  |  DISEASES
958  |  CD40  |  DISEASES
4318  |  MMP9  |  DISEASES
9682  |  KDM4A  |  DISEASES
4352  |  MPL  |  DISEASES
4904  |  YBX1  |  DISEASES
10864  |  SLC22A7  |  DISEASES
5328  |  PLAU  |  DISEASES
27232  |  GNMT  |  DISEASES
100  |  ADA  |  DISEASES
51021  |  MRPS16  |  DISEASES
84647  |  PLA2G12B  |  DISEASES
9436  |  NCR2  |  DISEASES
2022  |  ENG  |  DISEASES
2740  |  GLP1R  |  DISEASES
1025  |  CDK9  |  DISEASES
54657  |  UGT1A4  |  DISEASES
54577  |  UGT1A7  |  DISEASES
5292  |  PIM1  |  DISEASES
2833  |  CXCR3  |  DISEASES
2170  |  FABP3  |  DISEASES
4153  |  MBL2  |  DISEASES
22943  |  DKK1  |  DISEASES
7099  |  TLR4  |  DISEASES
9966  |  TNFSF15  |  DISEASES
23585  |  TMEM50A  |  DISEASES
240  |  ALOX5  |  DISEASES
1269  |  CNR2  |  DISEASES
7295  |  TXN  |  DISEASES
158833  |  AWAT1  |  DISEASES
1896  |  EDA  |  DISEASES
3339  |  HSPG2  |  DISEASES
11326  |  VSIG4  |  DISEASES
249  |  ALPL  |  DISEASES
229  |  ALDOB  |  DISEASES
5696  |  PSMB8  |  DISEASES
3127  |  HLA-DRB5  |  DISEASES
7046  |  TGFBR1  |  DISEASES
4855  |  NOTCH4  |  DISEASES
221527  |  ZBTB12  |  DISEASES
2159  |  F10  |  DISEASES
2155  |  F7  |  DISEASES
728239  |  MAGED4  |  DISEASES
3303  |  HSPA1A  |  DISEASES
57819  |  LSM2  |  DISEASES
6850  |  SYK  |  DISEASES
388595  |  TMEM82  |  DISEASES
23564  |  DDAH2  |  DISEASES
53358  |  SHC3  |  DISEASES
3055  |  HCK  |  DISEASES
10673  |  TNFSF13B  |  DISEASES
79070  |  KDELC1  |  DISEASES
50943  |  FOXP3  |  DISEASES
100507436  |  MICA  |  DISEASES
3107  |  HLA-C  |  DISEASES
64078  |  SLC28A3  |  DISEASES
7133  |  TNFRSF1B  |  DISEASES
3190  |  HNRNPK  |  DISEASES
1041  |  CDSN  |  DISEASES
729956  |  SHISA7  |  DISEASES
4879  |  NPPB  |  DISEASES
4878  |  NPPA  |  DISEASES
4524  |  MTHFR  |  DISEASES
3105  |  HLA-A  |  DISEASES
23412  |  COMMD3  |  DISEASES
10257  |  ABCC4  |  DISEASES
1471  |  CST3  |  DISEASES
10537  |  UBD  |  DISEASES
114798  |  SLITRK1  |  DISEASES
7056  |  THBD  |  DISEASES
1910  |  EDNRB  |  DISEASES
3274  |  HRH2  |  DISEASES
2512  |  FTL  |  DISEASES
3604  |  TNFRSF9  |  DISEASES
6461  |  SHB  |  DISEASES
8718  |  TNFRSF25  |  DISEASES
4609  |  MYC  |  DISEASES
414062  |  CCL3L3  |  DISEASES
3980  |  LIG3  |  DISEASES
2098  |  ESD  |  DISEASES
9308  |  CD83  |  DISEASES
5251  |  PHEX  |  DISEASES
1906  |  EDN1  |  DISEASES
3096  |  HIVEP1  |  DISEASES
9636  |  ISG15  |  DISEASES
444  |  ASPH  |  DISEASES
2308  |  FOXO1  |  DISEASES
1543  |  CYP1A1  |  DISEASES
1059  |  CENPB  |  DISEASES
23586  |  DDX58  |  DISEASES
25820  |  ARIH1  |  DISEASES
203102  |  ADAM32  |  DISEASES
5256  |  PHKA2  |  DISEASES
3559  |  IL2RA  |  DISEASES
10346  |  TRIM22  |  DISEASES
7010  |  TEK  |  DISEASES
91828  |  EXOC3L4  |  DISEASES
3704  |  ITPA  |  DISEASES
3440  |  IFNA2  |  DISEASES
3456  |  IFNB1  |  DISEASES
551  |  AVP  |  DISEASES
3045  |  HBD  |  DISEASES
6462  |  SHBG  |  DISEASES
5277  |  PIGA  |  DISEASES
7114  |  TMSB4X  |  DISEASES
3030  |  HADHA  |  DISEASES
51284  |  TLR7  |  DISEASES
1646  |  AKR1C2  |  DISEASES
1645  |  AKR1C1  |  DISEASES
3486  |  IGFBP3  |  DISEASES
4267  |  CD99  |  DISEASES
11082  |  ESM1  |  DISEASES
90865  |  IL33  |  DISEASES
53919  |  SLCO1C1  |  DISEASES
29126  |  CD274  |  DISEASES
3717  |  JAK2  |  DISEASES
192668  |  CYS1  |  DISEASES
3822  |  KLRC2  |  DISEASES
91543  |  RSAD2  |  DISEASES
51091  |  SEPSECS  |  DISEASES
9681  |  DEPDC5  |  DISEASES
23410  |  SIRT3  |  DISEASES
3083  |  HGFAC  |  DISEASES
2235  |  FECH  |  DISEASES
6736  |  SRY  |  DISEASES
51280  |  GOLM1  |  DISEASES
2878  |  GPX3  |  DISEASES
3875  |  KRT18  |  DISEASES
55576  |  STAB2  |  DISEASES
94  |  ACVRL1  |  DISEASES
238  |  ALK  |  DISEASES
4017  |  LOXL2  |  DISEASES
53345  |  TM6SF2  |  DISEASES
2877  |  GPX2  |  DISEASES
8878  |  SQSTM1  |  DISEASES
28227  |  PPP2R3B  |  DISEASES
79866  |  BORA  |  DISEASES
3811  |  KIR3DL1  |  DISEASES
250  |  ALPP  |  DISEASES
11262  |  SP140  |  DISEASES
29994  |  BAZ2B  |  DISEASES
51466  |  EVL  |  DISEASES
12  |  SERPINA3  |  DISEASES
10018  |  BCL2L11  |  DISEASES
114898  |  C1QTNF2  |  DISEASES
2172  |  FABP6  |  DISEASES
5627  |  PROS1  |  DISEASES
2719  |  GPC3  |  DISEASES
51520  |  LARS  |  DISEASES
9560  |  CCL4L2  |  DISEASES
6355  |  CCL8  |  DISEASES
130  |  ADH6  |  DISEASES
4891  |  SLC11A2  |  DISEASES
2875  |  GPT  |  DISEASES
6696  |  SPP1  |  DISEASES
3965  |  LGALS9  |  DISEASES
2643  |  GCH1  |  DISEASES
4239  |  MFAP4  |  DISEASES
2919  |  CXCL1  |  DISEASES
174  |  AFP  |  DISEASES
6387  |  CXCL12  |  DISEASES
27327  |  TNRC6A  |  DISEASES
655  |  BMP7  |  DISEASES
10379  |  IRF9  |  DISEASES
4780  |  NFE2L2  |  DISEASES
80380  |  PDCD1LG2  |  DISEASES
5609  |  MAP2K7  |  DISEASES
594857  |  NPS  |  DISEASES
4599  |  MX1  |  DISEASES
2950  |  GSTP1  |  DISEASES
1859  |  DYRK1A  |  DISEASES
3119  |  HLA-DQB1  |  DISEASES
1763  |  DNA2  |  DISEASES
10410  |  IFITM3  |  DISEASES
1654  |  DDX3X  |  DISEASES
8091  |  HMGA2  |  DISEASES
5970  |  RELA  |  DISEASES
6654  |  SOS1  |  DISEASES
2160  |  F11  |  DISEASES
60489  |  APOBEC3G  |  DISEASES
202018  |  TAPT1  |  DISEASES
728441  |  GGT2  |  DISEASES
164668  |  APOBEC3H  |  DISEASES
2011  |  MARK2  |  DISEASES
7018  |  TF  |  DISEASES
1363  |  CPE  |  DISEASES
210  |  ALAD  |  DISEASES
7852  |  CXCR4  |  DISEASES
3655  |  ITGA6  |  DISEASES
100190949  |  C5orf52  |  DISEASES
501  |  ALDH7A1  |  DISEASES
10989  |  IMMT  |  DISEASES
23066  |  CAND2  |  DISEASES
2641  |  GCG  |  DISEASES
4938  |  OAS1  |  DISEASES
4295  |  MLN  |  DISEASES
55577  |  NAGK  |  DISEASES
5601  |  MAPK9  |  DISEASES
6916  |  TBXAS1  |  DISEASES
91147  |  TMEM67  |  DISEASES
3120  |  HLA-DQB2  |  DISEASES
51099  |  ABHD5  |  DISEASES
3481  |  IGF2  |  DISEASES
10134  |  BCAP31  |  DISEASES
8671  |  SLC4A4  |  DISEASES
3113  |  HLA-DPA1  |  DISEASES
648791  |  PPP1R3G  |  DISEASES
197  |  AHSG  |  DISEASES
23210  |  JMJD6  |  DISEASES
85443  |  DCLK3  |  DISEASES
1029  |  CDKN2A  |  DISEASES
720  |  C4A  |  DISEASES
55665  |  URGCP  |  DISEASES
93349  |  SP140L  |  DISEASES
9080  |  CLDN9  |  DISEASES
79094  |  CHAC1  |  DISEASES
960  |  CD44  |  DISEASES
3702  |  ITK  |  DISEASES
7124  |  TNF  |  DISEASES
7264  |  TSTA3  |  DISEASES
3106  |  HLA-B  |  DISEASES
10165  |  SLC25A13  |  DISEASES
387  |  RHOA  |  DISEASES
4615  |  MYD88  |  DISEASES
57506  |  MAVS  |  DISEASES
5817  |  PVR  |  DISEASES
4049  |  LTA  |  DISEASES
388372  |  CCL4L1  |  DISEASES
6522  |  SLC4A2  |  DISEASES
9498  |  SLC4A8  |  DISEASES
3276  |  PRMT1  |  DISEASES
2876  |  GPX1  |  DISEASES
5830  |  PEX5  |  DISEASES
3115  |  HLA-DPB1  |  DISEASES
1154  |  CISH  |  DISEASES
834  |  CASP1  |  DISEASES
4050  |  LTB  |  DISEASES
2632  |  GBE1  |  DISEASES
3451  |  IFNA17  |  DISEASES
3586  |  IL10  |  DISEASES
3441  |  IFNA4  |  DISEASES
26065  |  LSM14A  |  DISEASES
5682  |  PSMA1  |  DISEASES
8842  |  PROM1  |  DISEASES
133396  |  IL31RA  |  DISEASES
721  |  C4B  |  DISEASES
57553  |  MICAL3  |  DISEASES
4193  |  MDM2  |  DISEASES
3077  |  HFE  |  DISEASES
374308  |  PTCHD3  |  DISEASES
338376  |  IFNE  |  DISEASES
3712  |  IVD  |  DISEASES
54659  |  UGT1A3  |  DISEASES
4700  |  NDUFA6  |  DISEASES
5478  |  PPIA  |  DISEASES
10209  |  EIF1  |  DISEASES
6256  |  RXRA  |  DISEASES
1316  |  KLF6  |  DISEASES
30816  |  ERVW-1  |  DISEASES
846  |  CASR  |  DISEASES
131  |  ADH7  |  DISEASES
7019  |  TFAM  |  DISEASES
2638  |  GC  |  DISEASES
51428  |  DDX41  |  DISEASES
100506742  |  CASP12  |  DISEASES
26064  |  RAI14  |  DISEASES
2920  |  CXCL2  |  DISEASES
1050  |  CEBPA  |  DISEASES
2994  |  GYPB  |  DISEASES
284  |  ANGPT1  |  DISEASES
151306  |  GPBAR1  |  DISEASES
51312  |  SLC25A37  |  DISEASES
4147  |  MATN2  |  DISEASES
9843  |  HEPH  |  DISEASES
3551  |  IKBKB  |  DISEASES
7033  |  TFF3  |  DISEASES
503542  |  SPRN  |  DISEASES
930  |  CD19  |  DISEASES
9414  |  TJP2  |  DISEASES
83695  |  RHNO1  |  DISEASES
441864  |  TARM1  |  DISEASES
3684  |  ITGAM  |  DISEASES
8284  |  KDM5D  |  DISEASES
11153  |  FICD  |  DISEASES
9971  |  NR1H4  |  DISEASES
7421  |  VDR  |  DISEASES
8972  |  MGAM  |  DISEASES
1649  |  DDIT3  |  DISEASES
84525  |  HOPX  |  DISEASES
26037  |  SIPA1L1  |  DISEASES
5228  |  PGF  |  DISEASES
8742  |  TNFSF12  |  DISEASES
567  |  B2M  |  DISEASES
11245  |  GPR176  |  DISEASES
101  |  ADAM8  |  DISEASES
3949  |  LDLR  |  DISEASES
5261  |  PHKG2  |  DISEASES
388588  |  SMIM1  |  DISEASES
820  |  CAMP  |  DISEASES
1506  |  CTRL  |  DISEASES
11201  |  POLI  |  DISEASES
84823  |  LMNB2  |  DISEASES
7138  |  TNNT1  |  DISEASES
284424  |  MIR7-3HG  |  DISEASES
246734  |  NPCDR1  |  DISEASES
6689  |  SPIB  |  DISEASES
6625  |  SNRNP70  |  DISEASES
7012  |  TERC  |  DISEASES
101669766  |  ZNF350-AS1  |  DISEASES
Locus(Waiting for update.)
Disease ID 675
Disease liver disease
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:226)
HP:0001394  |  Hepatic cirrhosis  |  175
HP:0012115  |  Liver inflammation  |  144
HP:0001513  |  Obesity  |  83
HP:0001402  |  Hepatocellular carcinoma  |  81
HP:0000855  |  Insulin resistance  |  75
HP:0030731  |  Carcinoma  |  64
HP:0000822  |  Hypertension  |  62
HP:0200123  |  Chronic liver inflammation  |  55
HP:0001409  |  Portal hypertension  |  54
HP:0001397  |  Hepatic steatosis  |  52
HP:0001395  |  Hepatic fibrosis  |  39
HP:0001541  |  Ascites  |  32
HP:0001298  |  Encephalopathy  |  31
HP:0001399  |  Liver failure  |  30
HP:0001873  |  Low platelet count  |  25
HP:0000819  |  Diabetes mellitus  |  24
HP:0003256  |  Coagulopathy  |  21
HP:0006562  |  Viral hepatitis  |  19
HP:0002480  |  Hepatic encephalopathy  |  19
HP:0000952  |  Yellow skin  |  19
HP:0001677  |  Coronary artery disease  |  16
HP:0002240  |  Enlarged liver  |  15
HP:0000083  |  Renal insufficiency  |  14
HP:0002664  |  Neoplasia  |  14
HP:0100512  |  Vitamin D deficiency  |  12
HP:0000989  |  pruritis  |  12
HP:0002910  |  Elevated transaminases  |  11
HP:0004395  |  Malnutrition  |  11
HP:0002621  |  Atherosclerosis  |  11
HP:0002721  |  Immunodeficiency  |  10
HP:0000939  |  Osteoporosis  |  10
HP:0002239  |  Gastrointestinal hemorrhage  |  9
HP:0001907  |  Thromboembolic disease  |  9
HP:0002584  |  Intestinal hemorrhage  |  9
HP:0002896  |  Liver cancer  |  9
HP:0000716  |  Depression  |  8
HP:0003774  |  End-stage renal failure  |  8
HP:0002092  |  Pulmonary artery hypertension  |  8
HP:0001396  |  Cholestasis  |  8
HP:0001903  |  Anemia  |  8
HP:0001824  |  Weight loss  |  7
HP:0001410  |  Decreased liver function  |  7
HP:0006554  |  Acute hepatic failure  |  7
HP:0000147  |  Sclerocystic ovaries  |  7
HP:0012622  |  Chronic kidney disease  |  6
HP:0002608  |  Celiac disease  |  6
HP:0003074  |  High blood glucose  |  5
HP:0100626  |  Chronic hepatic failure  |  5
HP:0001744  |  Splenomegaly  |  5
HP:0005912  |  Biliary duct atresia  |  5
HP:0030151  |  Cholangitis  |  5
HP:0000821  |  Underactive thyroid  |  5
HP:0002725  |  Systemic lupus erythematosus  |  5
HP:0200119  |  Acute liver inflammation  |  5
HP:0001635  |  Congestive heart failure  |  4
HP:0000833  |  Glucose intolerance  |  4
HP:0002902  |  Hyponatremia  |  4
HP:0012531  |  Pain  |  4
HP:0100806  |  Sepsis  |  4
HP:0002090  |  Pneumonia  |  4
HP:0001971  |  Hypersplenism  |  4
HP:0001919  |  Acute renal failure  |  4
HP:0012418  |  Low blood oxygen level  |  4
HP:0002904  |  High blood bilirubin levels  |  4
HP:0012378  |  Fatigue  |  4
HP:0002202  |  Pleural effusion  |  3
HP:0002716  |  Lymph node hyperplasia  |  3
HP:0001548  |  Overgrowth  |  3
HP:0000969  |  Dropsy  |  3
HP:0001945  |  Fever  |  3
HP:0001537  |  Umbilical hernias  |  3
HP:0000846  |  Hypoadrenalism  |  3
HP:0000113  |  Polycystic kidney dysplasia  |  3
HP:0002613  |  Biliary cirrhosis  |  3
HP:0000938  |  Decreased bone mineral density  |  3
HP:0000739  |  Anxiety  |  3
HP:0030153  |  Cholangiocarcinoma  |  3
HP:0100790  |  Hernia  |  3
HP:0030242  |  Blood clot in portal vein  |  3
HP:0002094  |  Dyspnea  |  3
HP:0002870  |  Obstructive sleep apnea  |  3
HP:0012743  |  Central obesity  |  3
HP:0010535  |  Sleep apnea  |  3
HP:0001878  |  Haemolytic anaemia  |  2
HP:0004936  |  Blood clot in vein  |  2
HP:0001259  |  Coma  |  2
HP:0001987  |  Hyperammonemia  |  2
HP:0000842  |  Elevated insulin level  |  2
HP:0001297  |  Cerebral vascular events  |  2
HP:0002615  |  Low blood pressure  |  2
HP:0002586  |  Peritonitis  |  2
HP:0002639  |  Budd-Chiari syndrome  |  2
HP:0003002  |  Breast carcinoma  |  2
HP:0000979  |  Purpura  |  2
HP:0002024  |  Intestinal malabsorption  |  2
HP:0003765  |  Psoriasis  |  2
HP:0001717  |  Coronary artery calcification  |  2
HP:0100753  |  Schizophrenia  |  2
HP:0002960  |  Autoimmune condition  |  2
HP:0002301  |  Hemiplegia  |  2
HP:0100324  |  Progressive systemic scleroderma  |  2
HP:0100543  |  Cognitive deficits  |  2
HP:0002104  |  Absence of spontaneous respiration  |  2
HP:0001928  |  Abnormal blood coagulation studies  |  2
HP:0000112  |  Nephropathy  |  2
HP:0001081  |  Gallstones  |  2
HP:0003077  |  Hyperlipidemia  |  2
HP:0012164  |  Asterixis  |  2
HP:0005202  |  Helicobacter pylori infection  |  2
HP:0002181  |  Cerebral edema  |  2
HP:0002020  |  Heartburn  |  2
HP:0002583  |  Colitis  |  2
HP:0000421  |  Bloody nose  |  2
HP:0003270  |  Distended abdomen  |  1
HP:0012578  |  Membranous glomerulonephritis  |  1
HP:0040171  |  Low serum testosterone levels  |  1
HP:0200063  |  Colorectal polyposis  |  1
HP:0001406  |  Intrahepatic cholestasis  |  1
HP:0002605  |  Hepatic necrosis  |  1
HP:0000802  |  Erectile dysfunction  |  1
HP:0002905  |  Hyperphosphatemia  |  1
HP:0012126  |  Gastric cancer  |  1
HP:0100602  |  Pre-eclampsia  |  1
HP:0012594  |  High urine albumin levels  |  1
HP:0100279  |  Ulcerative colitis  |  1
HP:0011675  |  Arrhythmias  |  1
HP:0100584  |  Endocarditis  |  1
HP:0002248  |  Vomitting blood  |  1
HP:0040184  |  Oral hemorrhage  |  1
HP:0000859  |  Mineralocorticoid excess  |  1
HP:0003394  |  Muscle cramps  |  1
HP:0003231  |  Increased tyrosine in blood  |  1
HP:0001272  |  Cerebellar atrophy  |  1
HP:0001875  |  Neutropenia  |  1
HP:0001712  |  Left ventricular hypertrophy  |  1
HP:0007634  |  Nonarteritic anterior ischemic optic neuropathy  |  1
HP:0002630  |  Fat malabsorption  |  1
HP:0012490  |  Inflammation of fat tissue  |  1
HP:0000967  |  Petechiae  |  1
HP:0011921  |  Exudative pleural effusion  |  1
HP:0100614  |  Muscle inflammation  |  1
HP:0004844  |  Coombs-positive hemolytic anemia  |  1
HP:0003155  |  Hyperphosphatasia  |  1
HP:0002633  |  Vasculitis  |  1
HP:0000752  |  Hyperactive behavior  |  1
HP:0002901  |  Hypocalcemia  |  1
HP:0002908  |  Conjugated hyperbilirubinemia  |  1
HP:0000206  |  Inflammation of the tongue  |  1
HP:0001880  |  Eosinophilia  |  1
HP:0002140  |  Ischemic stroke  |  1
HP:0003261  |  Elevated IgA  |  1
HP:0001733  |  Pancreatic inflammation  |  1
HP:0001892  |  Bleeding diathesis  |  1
HP:0007302  |  Bipolar disorder  |  1
HP:0000488  |  Noninflammatory retina disease  |  1
HP:0002955  |  Granulomatosis  |  1
HP:0008356  |  Combined hyperlipidaemia  |  1
HP:0002013  |  Emesis  |  1
HP:0002835  |  Aspiration  |  1
HP:0008282  |  Unconjugated hyperbilirubinemia  |  1
HP:0001370  |  Rheumatoid arthritis  |  1
HP:0009125  |  Lipodystrophy  |  1
HP:0010562  |  Keloids  |  1
HP:0004448  |  Fulminant hepatic failure  |  1
HP:0100009  |  Intracranial meningioma  |  1
HP:0004387  |  Enterocolitis  |  1
HP:0010702  |  Hypergammaglobulinaemia  |  1
HP:0002757  |  Multiple fractures  |  1
HP:0005978  |  Noninsulin dependent diabetes mellitus  |  1
HP:0012532  |  Chronic pain  |  1
HP:0000602  |  Ophthalmoplegia  |  1
HP:0001882  |  Decreased blood leukocyte number  |  1
HP:0001942  |  Metabolic acidosis  |  1
HP:0100778  |  Cryoglobulinemia  |  1
HP:0001622  |  Premature delivery  |  1
HP:0001251  |  Ataxia  |  1
HP:0001250  |  Seizures  |  1
HP:0100727  |  Histiocytosis  |  1
HP:0002749  |  Osteomalacia  |  1
HP:0001714  |  Ventricular hypertrophy  |  1
HP:0000988  |  Exanthem  |  1
HP:0002014  |  Diarrhea  |  1
HP:0002099  |  Asthma  |  1
HP:0030830  |  Crackles  |  1
HP:0001138  |  Damaged optic nerve  |  1
HP:0011106  |  Depleted blood volume  |  1
HP:0000166  |  Severe periodontal disease  |  1
HP:0012197  |  Insulinoma  |  1
HP:0001262  |  Somnolence  |  1
HP:0003202  |  Neurogenic muscle atrophy, especially in the lower limbs  |  1
HP:0100699  |  Scarring  |  1
HP:0001369  |  Arthritis  |  1
HP:0100723  |  Gastrointestinal stroma tumor  |  1
HP:0004929  |  Coronary artherosclerosis  |  1
HP:0001997  |  Gout  |  1
HP:0002829  |  Arthralgias  |  1
HP:0002360  |  Sleep disturbance  |  1
HP:0002624  |  Abnormal vein  |  1
HP:0001876  |  Low blood cell count  |  1
HP:0006280  |  Chronic pancreas inflammation  |  1
HP:0004787  |  Fulminant hepatitis  |  1
HP:0100724  |  Hypercoagulability  |  1
HP:0000107  |  Renal cyst  |  1
HP:0100896  |  Rectal polyps  |  1
HP:0001973  |  Autoimmune thrombocytopenia  |  1
HP:0001871  |  Abnormality of blood and blood-forming tissues  |  1
HP:0003201  |  Rhabdomyolysis  |  1
HP:0002189  |  Excessive daytime sleepiness  |  1
HP:0001342  |  Intracerebral hemorrhage  |  1
HP:0006580  |  Portal fibrosis  |  1
HP:0100537  |  Inflammation of the fascia  |  1
HP:0002597  |  Abnormality of blood vessels  |  1
HP:0100033  |  Tic disorder  |  1
HP:0006561  |  Lipid accumulation in hepatocytes  |  1
HP:0001300  |  Parkinsonism  |  1
HP:0005523  |  Lymphoproliferative disorder  |  1
HP:0000824  |  Growth hormone deficiency  |  1
HP:0002878  |  Respiratory failure  |  1
HP:0002578  |  Gastroparesis  |  1
HP:0002617  |  Aneurysmal dilatation  |  1
HP:0003075  |  Hypoproteinemia  |  1
HP:0005681  |  Juvenile idiopathic arthritis  |  1
HP:0001650  |  Valvular aortic stenosis  |  1
HP:0000978  |  Bruisability  |  1
HP:0001941  |  acidemia  |  1
HP:0030049  |  Brain abscess  |  1
Disease ID 675
Disease liver disease
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:81)
C0023890  |  cirrhosis  |  175
C0009450  |  infection  |  152
C0239946  |  liver fibrosis  |  87
C0019196  |  hepatitis c  |  69
C0011847  |  diabetes  |  69
C0796095  |  c syndrome  |  56
C0020541  |  portal hypertension  |  54
C0239946  |  hepatic fibrosis  |  39
C0085584  |  encephalopathy  |  31
C0021311  |  infections  |  31
C0426768  |  o sign  |  27
C0085605  |  liver failure  |  24
C0011849  |  diabetes mellitus  |  24
C0040034  |  thrombocytopenia  |  22
C0005779  |  coagulopathy  |  21
C0019151  |  hepatic encephalopathy  |  19
C0042769  |  virus infection  |  15
C0282193  |  iron overload  |  13
C0042870  |  vitamin d deficiency  |  12
C0033774  |  pruritus  |  12
C0004153  |  atherosclerosis  |  11
C0162429  |  malnutrition  |  11
C0035078  |  renal failure  |  10
C0040053  |  thrombosis  |  10
C0029456  |  osteoporosis  |  10
C0014867  |  esophageal varices  |  9
C0040038  |  thromboembolism  |  9
C0022658  |  renal disease  |  9
C0267373  |  intestinal bleeding  |  9
C0019080  |  hemorrhage  |  8
C0008370  |  cholestasis  |  8
C0235378  |  hepatotoxicity  |  8
C0020542  |  pulmonary hypertension  |  8
C0002871  |  anemia  |  7
C0019202  |  wilson's disease  |  5
C0036690  |  sepsis  |  4
C0001973  |  alcoholism  |  4
C0235950  |  zinc deficiency  |  4
C0015672  |  fatigue  |  4
C1393529  |  vascular complications  |  3
C0019163  |  hepatitis b infection  |  3
C0341697  |  renal impairment  |  3
C0001623  |  adrenal insufficiency  |  3
C0024228  |  lymphadenopathy  |  3
C0019322  |  umbilical hernia  |  3
C0442874  |  neuropathy  |  2
C0024523  |  malabsorption  |  2
C0004610  |  bacteremia  |  2
C0005944  |  metabolic bone disease  |  2
C0005779  |  coagulation disorders  |  2
C0004623  |  bacterial infections  |  2
C1619692  |  nephrogenic systemic fibrosis  |  2
C0027765  |  neurological disorder  |  2
C0005779  |  coagulopathies  |  2
C0022658  |  nephropathy  |  2
C0031154  |  peritonitis  |  2
C0162429  |  nutritional deficiencies  |  1
C0024115  |  lung disease  |  1
C0233401  |  psychiatric symptoms  |  1
C0005940  |  bone disorders  |  1
C0271650  |  glucose intolerance  |  1
C0014009  |  empyema  |  1
C0021053  |  immune disorders  |  1
C0235394  |  wasting  |  1
C0687751  |  spur cell anemia  |  1
C0004623  |  bacterial infection  |  1
C0008350  |  gallstones  |  1
C0037090  |  respiratory symptoms  |  1
C0268307  |  conjugated hyperbilirubinemia  |  1
C0002878  |  haemolytic anaemia  |  1
C0005750  |  stasis syndrome  |  1
C0002878  |  hemolytic anemia  |  1
C0022660  |  acute renal failure  |  1
C0020488  |  sodium retention  |  1
C0242350  |  erectile dysfunction  |  1
C1527311  |  brain edema  |  1
C0009324  |  ulcerative colitis  |  1
C0162316  |  iron deficiency  |  1
C0259749  |  autonomic neuropathy  |  1
C0221757  |  alpha-1-antitrypsin deficiency  |  1
C1839611  |  n syndrome  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:40)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs104894422181998616445SGCGumls:C0023895BeFreeMale C282Y homozygotes with a serum ferritin level of 1000 mug per liter or more were more likely to report fatigue, use of arthritis medicine, and a history of liver disease than were men who had the wild-type gene.0.0002714422008SGCG1323324513GA
rs121434622200110992332FMR1umls:C0023895BeFreeThis patient harbors an isoleucine to asparagine mutation (I304N) in the second FMRP KH-type RNA-binding domain, however, this single case report was complicated because the patient harbored a superimposed familial liver disease.0.0002714422009FMR1X147936534TA
rs122998422048268125ADH1Bumls:C0023895BeFreeThe aim of this study was to analyze the combined effect of the most frequent alcohol dehydrogenase polymorphisms (Arg48His and Arg370Cys in ADH1B, Arg272Gln and Ile350Val in ADH1C) on the alcohol use habits, alcohol dependence and chronic liver diseases in Hungary.0.0037242412011ADH1B499318162TC
rs1297986024914551282617IFNL3umls:C0023895BeFreeImpact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients.0.0024429772014IFNL3;IFNL41939248147CT
rs1297986025740255101180976IFNL4umls:C0023895BeFreeHere we demonstrate, using liver disease as a model, that a single-nucleotide polymorphism (rs12979860) in the intronic region of interferon-λ4 (IFNL4) is a strong predictor of fibrosis in an aetiology-independent manner.0.0002714422015IFNL3;IFNL41939248147CT
rs15049537222048268125ADH1Bumls:C0023895BeFreeThe aim of this study was to analyze the combined effect of the most frequent alcohol dehydrogenase polymorphisms (Arg48His and Arg370Cys in ADH1B, Arg272Gln and Ile350Val in ADH1C) on the alcohol use habits, alcohol dependence and chronic liver diseases in Hungary.0.0037242412011ADH1B499313834CT
rs169348222048268125ADH1Bumls:C0023895BeFreeThe aim of this study was to analyze the combined effect of the most frequent alcohol dehydrogenase polymorphisms (Arg48His and Arg370Cys in ADH1B, Arg272Gln and Ile350Val in ADH1C) on the alcohol use habits, alcohol dependence and chronic liver diseases in Hungary.0.0037242412011ADH1C499342808CT
rs1799945109259863077HFEumls:C0023895BeFreeThis study assessed liver biopsies containing stainable iron from 103 patients with various liver diseases; clinical information included hepatic iron concentration and HFE genotype (C282Y, H63D).0.0536360032000HFE626090951CG
rs1799945171602393077HFEumls:C0023895BeFreeMutation of the hemochromatosis gene (C282Y and/or H63D) was diagnosed in 16 (55.2%) patients with nonalcoholic steatohepatitis, in 12 (60%) patients with hepatitis C and in 8 (40%) patients with no liver disease.0.0536360032006HFE626090951CG
rs1799945126780563077HFEumls:C0023895BeFreeOur results show that the C282Y and H63D mutations of the HFE gene associated with hemochromatosis have measurable and consistent effects on iron indicators and are associated with liver disorders, but have no measurable effect on other iron overload-related symptoms and life-expectancy.0.0536360032002HFE626090951CG
rs1800562198929369843HEPHumls:C0023895BeFreeDuodenal biopsy samples were analyzed using real-time PCR for expression of DMT1, FPN1, DCYTB, and HEPH relative to GAPDH from 23 C282Y homozygotes, including 5 nonexpressors (serum ferritin < upper limit of normal and absence of phenotypic features of hemochromatosis) and 18 expressors. Four subjects of wild type for HFE mutations without iron overload or liver disease served as controls.0.0002714422010HFE626092913GA
rs1800562179047633077HFEumls:C0023895BeFreeHereditary hemochromatosis (HH) is a genetic disease associated with iron overload, in which individuals homozygous for the mutant C282Y HFE associated allele are at risk of developing liver disease, diabetes and arthritis.0.0536360032008HFE626092913GA
rs1800562198929363077HFEumls:C0023895BeFreeDuodenal biopsy samples were analyzed using real-time PCR for expression of DMT1, FPN1, DCYTB, and HEPH relative to GAPDH from 23 C282Y homozygotes, including 5 nonexpressors (serum ferritin < upper limit of normal and absence of phenotypic features of hemochromatosis) and 18 expressors. Four subjects of wild type for HFE mutations without iron overload or liver disease served as controls.0.0536360032010HFE626092913GA
rs180056296203443077HFEumls:C0023895BeFreeWe evaluated whether the recently described C282Y mutation of the hemochromatosis gene, designated HFE (responsible for at least 83% of hereditary hemochromatosis), was associated with more advanced liver disease in chronic hepatitis C. One hundred thirty-seven patients with biopsy-proven chronic hepatitis C were studied and liver biopsies scored for necroinflammation (grade 0-18) and fibrosis (stage 0-6).0.0536360031998HFE626092913GA
rs1800562109259863077HFEumls:C0023895BeFreeThis study assessed liver biopsies containing stainable iron from 103 patients with various liver diseases; clinical information included hepatic iron concentration and HFE genotype (C282Y, H63D).0.0536360032000HFE626092913GA
rs1800562171602393077HFEumls:C0023895BeFreeMutation of the hemochromatosis gene (C282Y and/or H63D) was diagnosed in 16 (55.2%) patients with nonalcoholic steatohepatitis, in 12 (60%) patients with hepatitis C and in 8 (40%) patients with no liver disease.0.0536360032006HFE626092913GA
rs1800562126780563077HFEumls:C0023895BeFreeOur results show that the C282Y and H63D mutations of the HFE gene associated with hemochromatosis have measurable and consistent effects on iron indicators and are associated with liver disorders, but have no measurable effect on other iron overload-related symptoms and life-expectancy.0.0536360032002HFE626092913GA
rs1800562158581863077HFEumls:C0023895BeFreeAmong men, C282Y homozygotes and compound heterozygotes were more likely to report a history of liver disease than were participants without HFE mutations.0.0536360032005HFE626092913GA
rs3538590222048268125ADH1Bumls:C0023895BeFreeThe aim of this study was to analyze the combined effect of the most frequent alcohol dehydrogenase polymorphisms (Arg48His and Arg370Cys in ADH1B, Arg272Gln and Ile350Val in ADH1C) on the alcohol use habits, alcohol dependence and chronic liver diseases in Hungary.0.0037242412011ADH1C499347122CT,A
rs386626619226843493717JAK2umls:C0023895BeFreeThe aim of this study was to describe the prevalence of main hereditary thrombophilias, Janus kinase 2 (JAK2) V617F mutation, antiphospholipid antibody syndrome (APS), and hyperhomocysteinemia in Brazilian children and adolescents diagnosed with portal vein thrombosis (PVT) without associated hepatic disease.0.0002714422012NANANANANA
rs4074242604932919CXCL1umls:C0023895BeFreePatients with alcohol-induced cirrhosis were significantly more often carriers of the CXCL1 rs4074 A allele (65.3%) than alcoholics without liver disease (54.8%, OR=1.55; 95%CI=1.025-2.350; p=0.04) and healthy controls (53.8%, OR=1.62; 95%CI=1.212-2.151; p=0.001).0.0002714422013CXCL1473870427AG
rs4898235636287076TIMP1umls:C0023895BeFreeWe used PCR to analyze 188 patients with HCV-related liver disease (95 with chronic hepatitis and 93 with cirrhosis) for TIMP-1 372 T/C and TIMP-2 -418 G/C polymorphisms.0.0008143262012SYN1;TIMP1;MIR4769X47585586TC
rs5586807822048268125ADH1Bumls:C0023895BeFreeThe aim of this study was to analyze the combined effect of the most frequent alcohol dehydrogenase polymorphisms (Arg48His and Arg370Cys in ADH1B, Arg272Gln and Ile350Val in ADH1C) on the alcohol use habits, alcohol dependence and chronic liver diseases in Hungary.0.0037242412011NANANANANA
rs56061981240237753627CXCL10umls:C0023895BeFreeG-201A in promoter region of IP-10 gene was associated with liver disease progression in patients with HBV infection through up-regulating IP-10 expression.0.0010857672013ART3;CXCL10476023632CT
rs6742053122048268125ADH1Bumls:C0023895BeFreeThe aim of this study was to analyze the combined effect of the most frequent alcohol dehydrogenase polymorphisms (Arg48His and Arg370Cys in ADH1B, Arg272Gln and Ile350Val in ADH1C) on the alcohol use habits, alcohol dependence and chronic liver diseases in Hungary.0.0037242412011ADH1C499336772GA,C
rs69822048268125ADH1Bumls:C0023895BeFreeThe aim of this study was to analyze the combined effect of the most frequent alcohol dehydrogenase polymorphisms (Arg48His and Arg370Cys in ADH1B, Arg272Gln and Ile350Val in ADH1C) on the alcohol use habits, alcohol dependence and chronic liver diseases in Hungary.0.0037242412011ADH1C499339632TC,A
rs69919473084183AGTumls:C0023895BeFreeEvaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologies.0.0029099162009AGT1230710048AG
rs7384092306947680339PNPLA3umls:C0023895BeFreeSeveral studies have reported an association between the genetic variant rs738409 (G) in the PNPLA3 gene and the risk of cirrhosis in various liver diseases.0.0075244282013PNPLA32243928847CG
rs7384092174528680339PNPLA3umls:C0023895BeFreePNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.0.0075244282011PNPLA32243928847CG
rs7384092289848880339PNPLA3umls:C0023895BeFreeAim of this study was to evaluate whether the I148M PNPLA3 polymorphism influences serum adiponectin in liver diseases and healthy controls.0.0075244282012PNPLA32243928847CG
rs7384092356458080339PNPLA3umls:C0023895BeFreeRecently, the rs738409 I148M patatin-like phospholipase domain-containing 3 (PNPLA3) polymorphism has been demonstrated to influence steatosis susceptibility and fibrosis progression in patients with different liver diseases, but no data are yet available for CHB.0.0075244282013PNPLA32243928847CG
rs7384092387266980339PNPLA3umls:C0023895BeFreeThe G-allele in position rs738409 of patatin-like phospholipase domain-containing protein 3 (PNPLA3) is associated with an increased hepatic concentration of triglyceride and is a risk factor for advanced liver disease.0.0075244282013PNPLA32243928847CG
rs7384092411480980339PNPLA3umls:C0023895BeFreeA variant (rs738409 C>G, encoding for p.I148M) in the PNPLA3 gene is associated with liver damage in chronic liver diseases.0.0075244282013PNPLA32243928847CG
rs7384092422294180339PNPLA3umls:C0023895BeFreePNPLA3 I148M polymorphism and progressive liver disease.0.0075244282013PNPLA32243928847CG
rs7384092333310380339PNPLA3umls:C0023895BeFreeThe rs738409 genetic variant in the patatin-like phospholipase domain-containing 3 (PNPLA3, adiponutrin) gene has been implicated as a genetic determinant of the entire spectrum of liver diseases, ranging from steatosis, chronic hepatitis, cirrhosis and ultimately to HCC.0.0075244282012PNPLA32243928847CG
rs7384092286915780339PNPLA3umls:C0023895BeFreeThis study was conducted to determine whether PNPLA3 rs738409 SNPs affect development and prognosis of hepatocellular carcinoma (HCC) in patients with various liver diseases.0.0075244282013PNPLA32243928847CG
rs7384092537865680339PNPLA3umls:C0023895BeFreeThe human patatin-like phospholipase domain-containing-3 (PNPLA3) gene rs738409 C>G polymorphism is associated with several types of liver disease.0.0075244282015PNPLA32243928847CG
rs7384092562471280339PNPLA3umls:C0023895BeFreeVarious studies have established a strong link between the 148 isoleucine to methionine protein variant (I148M) of PNPLA3 and liver diseases, including nonalcoholic fatty liver disease (NAFLD).0.0075244282014PNPLA32243928847CG
rs77375493226843493717JAK2umls:C0023895BeFreeThe aim of this study was to describe the prevalence of main hereditary thrombophilias, Janus kinase 2 (JAK2) V617F mutation, antiphospholipid antibody syndrome (APS), and hyperhomocysteinemia in Brazilian children and adolescents diagnosed with portal vein thrombosis (PVT) without associated hepatic disease.0.0002714422012JAK2;INSL695073770GA,T
rs809991724914551282617IFNL3umls:C0023895BeFreeImpact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients.0.0024429772014NA1939252525TG
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:174)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
116505320rs1497406AGrs1497406220017573.00E-19NA3.8[2.70-4.80] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers1497406-GNA
121766453rs1976403ACrs1976403220017572.00E-50NA3.6[3.0-4.2] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers1976403-CNA
121821757rs1780324AGrs1780324189403127.00E-15ALP0.03[0.023-0.039] U/L increase7,751 European ancestry individualsEuropean(7751)ALL(7751)EUR(7751)ALL(7751)Liver enzyme levelsHPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004582alkaline phosphatase measurementLiver diseasers1780324-TResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., IntramuralC
167719129rs1343151GArs1343151211777731.91E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
176899464rs4949718TCrs4949718241244111.00E-06NA0.03[0.016-0.036] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers4949718-ANATST6GALNAC3
176899464rs4949718TCrs4949718241244112.00E-07NA0.05[0.033-0.073] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers4949718-ANATST6GALNAC3
189146234rs12145922CArs12145922220017574.00E-11NA2.8[2.20-3.40] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers12145922-ANA
1111684276rs1335645AGrs1335645220017577.00E-09NA4.3[3.50-5.20] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers1335645-ANA
1155126948rs10908458TCrs10908458220017572.00E-15NA3.7[3.10-4.20] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers10908458-TNA
1163142555rs12035879GArs12035879241244114.00E-06NA0.05[0.028-0.068] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers12035879-ANAARGS5
1165175515rs1354510AGrs1354510211777737.78E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1165180089rs1532815TArs1532815211777736.00E-07NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1167156500rs9803659TCrs9803659189403124.00E-06ALT0.03[0.018-0.042] U/L decrease7,751 European ancestry individualsEuropean(7751)ALL(7751)EUR(7751)ALL(7751)Liver enzyme levelsHPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004582alkaline phosphatase measurementLiver diseasers9803659-CResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., IntramuralC
1204112984rs3795578GArs3795578211777737.00E-06NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1205554085rs7526132GCrs7526132211777733.87E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
227730940rs1260326TCrs1260326220017574.00E-13NA3.2[2.40-4.0] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers1260326-TNA
2137873347rs892877AGrs892877241244114.00E-06NA0.03[0.018-0.046] unit decrease484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers892877-ANACTHSD7B
2137898753rs984295GArs984295241244115.86E-06NA0.03[0.02-0.04] unit decrease484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers984295-GNAATHSD7B
2150564484rs17801127CTrs17801127241244112.00E-07NA0.15[0.097-0.211] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers17801127-ANACNA
2152481977rs10186482AGrs10186482211777736.87E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2155234318rs12621256AGrs12621256241244114.00E-06NA0.09[0.053-0.131] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers12621256-GNAAGALNT13
2155647819rs17640676GTrs17640676211777732.09E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2169840574rs16856332TGrs16856332220017572.00E-09NA3.9[1.20-6.70] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers16856332-TNA
2192117238rs13030978CTrs13030978220017571.00E-11NA3.7[2.80-4.6] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers13030978-TNA
2203062103rs13015146TCrs13015146211777739.49E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2215024392rs16851554TGrs16851554211777732.46E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2233513175rs2140773CArs2140773220017571.00E-09NA2.9[2.30-3.50] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers2140773-ANA
2240216021rs6737742GArs6737742211777735.53E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2240217522rs908262CArs908262211777733.71E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
323712616rs11129122AGrs11129122211777734.97E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
352532118rs13326165AGrs13326165211777737.92E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
364536648rs80311637CTrs80311637241244112.00E-06NA0.08[0.047-0.109] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers80311637-ANACADAMTS9
364536648rs80311637CTrs80311637241244117.00E-06NA0.14[0.078-0.196] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers80311637-ANACADAMTS9
379604064rs7617400CTrs7617400241244116.00E-06NA0.03[0.02-0.048] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers7617400-ANACROBO1
379610625rs11924965CTrs11924965241244116.16E-06NA0.03[0.02-0.05] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers11924965-ANATROBO1
379646157rs7644918ACrs7644918241244116.97E-06NA0.03[0.02-0.05] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers7644918-CNACROBO1
388479786rs4563418GArs4563418211777733.87E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
388524175rs2880961CTrs2880961211777732.00E-07NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
3104446688rs777952CTrs777952211777735.73E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
3107589551rs6789170GTrs6789170211777733.63E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
3170725542rs10513686GArs10513686220017576.00E-11NA4.9[4.00-5.70] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers10513686-ANA
420515670rs6810790GArs6810790211777738.17E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
431208611rs9997440ATrs9997440211777733.83E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
488213808rs6834314AGrs6834314220017573.00E-09NA2.6[1.90-3.40] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers6834314-ANA
4126939153rs4495049ACrs4495049211777739.43E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
4146794621rs4547811TCrs4547811220017573.00E-27NA6.4[5.00-7.90] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers4547811-CNA
4175300604rs6553786CTrs6553786211777738.16E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
4175300779rs6852435TCrs6852435211777736.00E-06NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
4175325686rs7665426GTrs7665426211777732.17E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
4179675395rs2082603CTrs2082603211777733.43E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
531020521rs6888304AGrs6888304220017571.00E-09NA2.7[2.00-3.50] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers6888304-ANA
531113414rs16900696CGrs16900696211777737.12E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
552193125rs4074793AGrs4074793220017573.00E-10NA5.5[3.30-7.70] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers4074793-GNA
586122767rs7726138AGrs7726138211777735.44E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
594425542rs4869233TCrs4869233211777732.28E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
5116207905rs6878801CTrs6878801211777736.77E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
5134250146rs319594CTrs319594211777736.51E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
5134254788rs319590GTrs319590211777732.76E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
5134267557rs10515465GCrs10515465211777734.69E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
621946612rs13204006AGrs13204006211777737.85E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
624441746rs9467160GArs9467160189403121.00E-11ALP0.03[0.024-0.044] U/L increase7,751 European ancestry individualsEuropean(7751)ALL(7751)EUR(7751)ALL(7751)Liver enzyme levelsHPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004582alkaline phosphatase measurementLiver diseasers9467160-AResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., IntramuralG
624489652rs1126617CTrs1126617220017571.80E-14NANANAUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseaseNANA
624491475rs1883415ACrs1883415220017576.00E-26NA3.1[2.50-3.70] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers1883415-CNA
632305979rs3129900GTrs3129900206398787.00E-25NA7.5[5.00-11.30] 41 cases; 176 controlsNOPOP(217)ALL(217)NOPOP(217)ALL(217)Lumiracoxib-related liver injuryHPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004228drug-induced liver injuryLiver diseaseNANATC6orf10
650834157rs9473924GTrs9473924211777738.49E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
650857995rs9473932GArs9473932211777733.26E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
650865820rs943005CTrs943005211777737.78E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
650897251rs4715210CTrs4715210211777737.75E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
650905067rs3857596CTrs3857596211777737.75E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
653924697rs9296736TCrs9296736220017573.00E-09NA3[2.10-4.00] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers9296736-TNA
667497830rs4710625CGrs4710625211777738.39E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
688916603rs7738812ATrs7738812211777738.52E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
6112573289rs3208829CGrs3208829211777732.54E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
6112578384rs11153350GArs11153350211777732.54E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
6116128906rs10485114CTrs10485114211777734.01E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
6125574509rs3799732TCrs3799732211777736.49E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
722763009rs12700386CGrs12700386211777736.20E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
749519619rs11766607AGrs11766607211777732.06E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
749534244rs6949916AGrs6949916211777738.53E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
749556594rs4289753AGrs4289753211777737.19E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
773026378rs17145750CTrs17145750220017573.00E-09NA4.5[2.90-6.30] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers17145750-CNA
777985583rs17413355CTrs17413355211777738.50E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
7134564363rs2218988TCrs2218988211777739.50E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
89178268rs6984305ATrs6984305220017572.00E-10NA2.7[1.10-4.40] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers6984305-ANA
821102896rs718068TCrs718068211777735.25E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
821104408rs1380292AGrs1380292211777737.64E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
821118224rs1599096CTrs1599096211777736.86E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
827583328rs17469886CArs17469886211777733.52E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
836847115rs10110651TCrs10110651211777732.14E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
857926726rs2089515CTrs2089515211777739.91E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
868734769rs4585742GArs4585742211777736.05E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
8126482077rs2954021AGrs2954021220017572.00E-13NA1.4[0.50-2.30] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers2954021-ANA
8126482077rs2954021AGrs2954021220017575.00E-09NA1.6[0.60-2.60] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers2954021-ANA
8129083459rs2720666GArs2720666211777736.93E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
8129083584rs2720667GArs2720667211777735.73E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
9953057rs279874CGrs279874211777739.13E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
9104223233rs10819937CGrs10819937220017571.00E-09NA2.5[1.40-3.60] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers10819937-CNA
9136139265rs657152CArs657152189403122.00E-30ALP0.05[0.039-0.055] U/L decrease7,751 European ancestry individualsEuropean(7751)ALL(7751)EUR(7751)ALL(7751)Liver enzyme levelsHPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004582alkaline phosphatase measurementLiver diseasers657152-TResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., IntramuralT
9136154168rs579459TCrs579459220017573.00E-123NA8.8[7.40-10.2] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers579459-TNA
9136323754rs4962153AGrs4962153189403128.00E-21ALP0.06[0.048-0.072] U/L decrease7,751 European ancestry individualsEuropean(7751)ALL(7751)EUR(7751)ALL(7751)Liver enzyme levelsHPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004582alkaline phosphatase measurementLiver diseasers4962153-AResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., IntramuralG
101675548rs12267329AGrs12267329211777736.71E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1011224665rs596406TCrs596406241244114.00E-07NA0.07[0.042-0.092] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers596406-GNATCELF2
1011224665rs596406TCrs596406241244119.00E-06NA0.11[0.063-0.157] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers596406-GNATCELF2
1065121565rs12355784CArs12355784189403125.00E-10ALP0.03[0.017-0.033] U/L increase7,751 European ancestry individualsEuropean(7751)ALL(7751)EUR(7751)ALL(7751)Liver enzyme levelsHPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004582alkaline phosphatase measurementLiver diseasers12355784-AResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., IntramuralC
1065133822rs7923609AGrs7923609220017576.00E-23NA2.2[1.70-2.70] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers7923609-GNA
1065274927rs10761779AGrs10761779189403127.00E-10ALP0.03[0.017-0.033] U/L increase7,751 European ancestry individualsEuropean(7751)ALL(7751)EUR(7751)ALL(7751)Liver enzyme levelsHPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004582alkaline phosphatase measurementLiver diseasers10761779-GResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., IntramuralA
1079680434rs754466ATrs754466220017576.00E-10NA3.5[2.20-4.80] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers754466-TNA
10101157438rs76850691GCrs76850691241244119.00E-07NA0.1[0.06-0.138] unit decrease484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers76850691-CNAGGOT1
10101795361rs10883437TArs10883437220017574.00E-09NA2.3[1.40-3.10] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers10883437-TNA
10101861435rs11597390GArs11597390189403122.00E-08ALT0.04[0.025-0.053] U/L decrease7,751 European ancestry individualsEuropean(7751)ALL(7751)EUR(7751)ALL(7751)Liver enzyme levelsHPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004582alkaline phosphatase measurementLiver diseasers11597390-AResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., IntramuralA
1161623140rs174601CTrs174601220017573.00E-09NA1.7[0.80-2.60] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers174601-TNA
1161687674rs2524290GArs2524290211777736.19E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
11126283785rs2236653CTrs2236653220017572.00E-09NA1.5[0.60-2.50] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers2236653-TNA
11130698539rs948999CTrs948999211777736.95E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
126327008rs10849421AGrs10849421211777734.15E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
126327989rs4764486TCrs4764486211777735.27E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1241721235rs1880889ACrs1880889236968811.96E-08NANANA1210 individualsNOPOP(1210)ALL(1210)NOPOP(1210)ALL(1210)Alkaline phosphatase (ALP)HPOID:0001392Abnormality of the liverDOID:409liver diseaseNANANANALiver diseaseNAResearch Support, Non-U.S. Gov'tGPDZRN4
1297685364rs11611637TCrs11611637211777738.78E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
12121424861rs7310409AGrs7310409220017577.00E-45NA6.8[5.70-7.80] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers7310409-GNA
12121442670rs1169313TA,Crs1169313189403122.00E-10GGT0.01[0.003-0.007] U/L decrease7,751 European ancestry individualsEuropean(7751)ALL(7751)EUR(7751)ALL(7751)Liver enzyme levelsHPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004582alkaline phosphatase measurementLiver diseasers1169313-CResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., IntramuralC
1329558694rs9508207CTrs9508207211777736.79E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1339675022rs2209631GArs2209631211777737.28E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1339675421rs1536343TCrs1536343211777737.28E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1426488467rs862946TCrs862946241244112.00E-07NA0.04[0.027-0.059] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers862946-ANAGNA
1495911835rs10144421TCrs10144421211777738.77E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
14103572815rs944002AGrs944002220017576.00E-29NA6.3[4.90-7.70] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers944002-GNA
1560883281rs339969CArs339969220017577.00E-20NA4.5[3.90-5.10] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers339969-ANA
1573978337rs8038465CTrs8038465220017571.00E-09NA2.4[1.80-3.00] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers8038465-TNA
15101445900rs3825924GArs3825924211777731.73E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
161241997rs11248859GArs11248859211777736.18E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1650437528rs9941219CTrs9941219241244114.00E-06NA0.15[0.089-0.219] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers9941219-ANACNA
1650441208rs731660CArs731660241244114.06E-06NA0.15[0.09-0.22] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers731660-ANAGNA
1672220373rs7186908GCrs7186908220017575.00E-09NA2[1.10-2.90] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers7186908-CNA
1680497601rs4581712CArs4581712220017573.00E-09NA3.2[2.50-3.90] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers4581712-ANA
172729652rs6502555TCrs6502555211777733.11E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
176686566rs8081984TGrs8081984211777737.46E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
176692841rs10852886TArs10852886211777737.50E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
177091650rs314253TCrs314253220017578.00E-12NA2.1[1.50-2.80] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers314253-CNA
1770098161rs9913711GCrs9913711220017571.00E-09NA2.4[1.80-3.00] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers9913711-CNA
1770692740rs2567513CTrs2567513211777736.66E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1771061934rs903107TCrs903107241244116.00E-06NA0.1[0.059-0.149] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers903107-GNAASLC39A11
1772956124rs3744198GArs3744198211777733.40E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1828017919rs1372940CTrs1372940211777735.74E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
1855322502rs12968116CTrs12968116220017579.00E-10NA4.8[2.80-6.70] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers12968116-CNA
1856084054rs4503880TCrs4503880220017573.00E-12NA3.6[2.50-4.70] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers4503880-TNA
1866544755rs1539893GArs1539893241244113.00E-06NA0.06[0.035-0.085] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers1539893-GNATCCDC102B
1949206172rs516246CTrs516246220017578.00E-10NA2.3[1.80-2.90] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers516246-TNA
1949206603rs281377CTrs281377220017571.00E-15NA1.8[0.80-2.80] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers281377-TNA
1949206674rs601338GArs601338220017571.40E-08NANANAUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseaseNANA
201929542rs6035126CTrs6035126241244115.00E-06NA0.18[0.1-0.25] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers6035126-ANACNA
201931500rs13433286AGrs13433286241244114.94E-06NA0.18[0.1-0.25] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers13433286-GNAANA
2023141445rs844914ACrs844914241244115.98E-06NA0.11[0.06-0.16] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers844914-ANACNA
2023141655rs844917TCrs844917241244116.00E-06NA0.11[0.064-0.158] unit increase484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers844917-ANACNA
2023863795rs6083315GArs6083315211777737.52E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2025298087rs7267979AGrs7267979220017577.00E-10NA1.5[0.90-2.0] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alkaline phosphatase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004533alkaline phosphatase measurementLiver diseasers7267979-GNA
2044403710rs2064504AGrs2064504211777738.52E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2044404647rs6124741CTrs6124741211777738.31E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2044422705rs6032545GTrs6032545211777736.48E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2128657949rs457603CTrs457603241244115.00E-06NA0.07[0.041-0.099] unit decrease484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers457603-GNATNA
2128659396rs452621TCrs452621241244114.57E-06NA0.07[0.04-0.1] unit decrease484 Korean ancestry childrenKorean(484)ALL(484)ASN(484)ALL(484)Liver enzyme levels (aspartate transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANANANALiver diseasers452621-ANACNA
2142884031rs9984523CTrs9984523211777738.76E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2143822402rs11909987CArs11909987211777733.62E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2143823736rs9784215CArs9784215211777732.73E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2143826344rs3746923CTrs3746923211777732.56E-05NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
2218439958rs1076540CTrs1076540220017571.00E-16NA4.8[3.50-6.10] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers1076540-CNA
2224295286rs2739330TCrs2739330220017572.00E-09NA3.7[2.70-4.60] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers2739330-TNA
2224990213rs4820599AGrs4820599189403124.00E-11GGT0.01[0.005-0.009] U/L increase7,751 European ancestry individualsEuropean(7751)ALL(7751)EUR(7751)ALL(7751)Liver enzyme levelsHPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004582alkaline phosphatase measurementLiver diseasers4820599-GResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., IntramuralG
2224995756rs2006227CArs2006227236968810.000000017NANANA1210 individualsNOPOP(1210)ALL(1210)NOPOP(1210)ALL(1210)Gamma-glutamyl transferase (GGT)HPOID:0001392Abnormality of the liverDOID:409liver diseaseNANANANALiver diseaseNAResearch Support, Non-U.S. Gov'tCGGT1
2224996582rs2330795GArs2330795220017578.80E-18NANANAUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseaseNANA
2224997309rs2017869GCrs2017869236968817.94E-08NANANA1210 individualsNOPOP(1210)ALL(1210)NOPOP(1210)ALL(1210)Gamma-glutamyl transferase (GGT)HPOID:0001392Abnormality of the liverDOID:409liver diseaseNANANANALiver diseaseNAResearch Support, Non-U.S. Gov'tCGGT1
2224999104rs2073398CGrs2073398220017571.00E-109NA12.3[10.90-13.70] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (gamma-glutamyl transferase)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056486Drug-Induced Liver InjuryEFOID:0004532serum gamma-glutamyl transferase measurementLiver diseasers2073398-GNA
2244324727rs738409CGrs738409220017571.00E-45NA6[5.0-7.0] % increaseUp to 52,350 European ancestry individuals; up to 8,739 Indian Asian individualsEuropean(52350)Indian Asian(8739)ALL(61089)EUR(52350)SAN(8739)ALL(61089)Liver enzyme levels (alanine transaminase)HPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004735serum alanine aminotransferase measurementLiver diseasers738409-GNA
2244332570rs2281135GArs2281135189403128.00E-16ALT0.06[0.046-0.074] U/L increase7,751 European ancestry individualsEuropean(7751)ALL(7751)EUR(7751)ALL(7751)Liver enzyme levelsHPOID:0001410Decreased liver functionDOID:409liver diseaseNANAEFOID:0004582alkaline phosphatase measurementLiver diseasers2281135-TResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., IntramuralT
X147324256rs5936441CTrs5936441211777735.00E-06NANANA60 Caucasian American lymphoblastoid cell lines; 56 African American lymphoblastoid cell lines; 60 Han Chinese American lymphoblastoid cell linesHan Chinese American(60)Caucasian American(60)African American(56)ALL(176)ASN(60)AFR(56)EUR(60)ALL(176)Response to acetaminophen (hepatotoxicity)HPOID:0001392Abnormality of the liverDOID:409liver diseaseD056487Drug-Induced Liver Injury, ChronicNANALiver disease
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:67)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0023895acetaminophenD000082103-90-2liver diseasesMESH:D008107marker/mechanism11587558
C0023895acetylcysteineD000111616-91-1liver diseasesMESH:D008107therapeutic16922458
C0023895s-adenosylmethionineD01243629908-03-0liver diseasesMESH:D008107therapeutic1327655
C0023895amphetamineD000661300-62-9liver diseasesMESH:D008107marker/mechanism8099372
C0023895busulfanD00206655-98-1liver diseasesMESH:D008107marker/mechanism10955873
C0023895capsaicinD002211404-86-4liver diseasesMESH:D008107therapeutic16956363
C0023895carmustineD002330154-93-8liver diseasesMESH:D008107marker/mechanism10918425
C0023895ceftazidimeD00244278439-06-2liver diseasesMESH:D008107therapeutic21227004
C0023895celecoxibD000068579-liver diseasesMESH:D008107marker/mechanism19007904
C0023895cephalexinD00250615686-71-2liver diseasesMESH:D008107marker/mechanism7479194
C0023895chlorpromazineD00274650-53-3liver diseasesMESH:D008107marker/mechanism1175890
C0023895cholic acidD01982681-25-4liver diseasesMESH:D008107marker/mechanism25344563
C0023895cimetidineD00292751481-61-9liver diseasesMESH:D008107therapeutic6141900
C0023895clozapineD0030245786-21-0liver diseasesMESH:D008107marker/mechanism8121527
C0023895colchicineD00307864-86-8liver diseasesMESH:D008107marker/mechanism10455999
C0023895cyclophosphamideD00352050-18-0liver diseasesMESH:D008107marker/mechanism17580253
C0023895cyclosporineD01657259865-13-3liver diseasesMESH:D008107marker/mechanism10455999
C0023895dapsoneD00362280-08-0liver diseasesMESH:D008107marker/mechanism15947852
C0023895daptomycinD017576103060-53-3liver diseasesMESH:D008107marker/mechanism18381844
C0023895diclofenacD00400815307-86-5liver diseasesMESH:D008107marker/mechanism14566034
C0023895diltiazemD00411042399-41-7liver diseasesMESH:D008107therapeutic1472086
C0023895disopyramideD0042063737/9/5liver diseasesMESH:D008107marker/mechanism6834895
C0023895doxycyclineD004318564-25-0liver diseasesMESH:D008107marker/mechanism13130401
C0023895enalaprilD00465675847-73-3liver diseasesMESH:D008107marker/mechanism1880490
C0023895enfluraneD00473713838-16-9liver diseasesMESH:D008107marker/mechanism7647582
C0023895ethambutolD00497774-55-5liver diseasesMESH:D008107marker/mechanism10599213
C0023895ethosuximideD00501377-67-8liver diseasesMESH:D008107marker/mechanism6847455
C0023895floxuridineD00546750-91-9liver diseasesMESH:D008107marker/mechanism2522675
C0023895fluconazoleD01572586386-73-4liver diseasesMESH:D008107marker/mechanism14966256
C0023895fluconazoleD01572586386-73-4liver diseasesMESH:D008107therapeutic17580253
C0023895fluorouracilD00547251-21-8liver diseasesMESH:D008107marker/mechanism8862076
C0023895flutamideD00548513311-84-7liver diseasesMESH:D008107marker/mechanism10431581
C0023895fluvoxamineD01666654739-18-3liver diseasesMESH:D008107marker/mechanism15349014
C0023895folic acidD00549259-30-3liver diseasesMESH:D008107marker/mechanism16877991
C0023895fosinoprilD01732898048-97-6liver diseasesMESH:D008107marker/mechanism11941910
C0023895haloperidolD00622052-86-8liver diseasesMESH:D008107marker/mechanism595591
C0023895heminD00642716009-13-5liver diseasesMESH:D008107therapeutic17173083
C0023895imatinib mesylateD000068877-liver diseasesMESH:D008107marker/mechanism17364993
C0023895indomethacinD00721353-86-1liver diseasesMESH:D008107marker/mechanism15784032
C0023895labetalolD00774136894-69-6liver diseasesMESH:D008107marker/mechanism8124849
C0023895lindaneD00155658-89-9liver diseasesMESH:D008107marker/mechanism1715830
C0023895mebendazoleD00846331431-39-7liver diseasesMESH:D008107marker/mechanism21254932
C0023895melphalanD008558148-82-3liver diseasesMESH:D008107marker/mechanism10955873
C0023895metforminD008687657-24-9liver diseasesMESH:D008107marker/mechanism10216414
C0023895methotrexateD0087271959/5/2liver diseasesMESH:D008107marker/mechanism1058041
C0023895mitoxantroneD00894265271-80-9liver diseasesMESH:D008107marker/mechanism20427751
C0023895nevirapineD019829129618-40-2liver diseasesMESH:D008107marker/mechanism18261327
C0023895nicotineD009538-liver diseasesMESH:D008107marker/mechanism15925865
C0023895phenytoinD01067257-41-0liver diseasesMESH:D008107marker/mechanism14986274
C0023895piroxicamD01089436322-90-4liver diseasesMESH:D008107marker/mechanism16867024
C0023895propranololD011433525-66-6liver diseasesMESH:D008107therapeutic11193444
C0023895rifampinD01229313292-46-1liver diseasesMESH:D008107marker/mechanism10599213
C0023895ritonavirD019438-liver diseasesMESH:D008107marker/mechanism20003457
C0023895rofecoxibC116926-liver diseasesMESH:D008107marker/mechanism15834531
C0023895rosiglitazoneC089730-liver diseasesMESH:D008107marker/mechanism14562008
C0023895streptozocinD01331118883-66-4liver diseasesMESH:D008107marker/mechanism135666
C0023895sulindacD01346738194-50-2liver diseasesMESH:D008107marker/mechanism14566034
C0023895tenoxicamC03280159804-37-4liver diseasesMESH:D008107marker/mechanism16867024
C0023895thiotepaD01385252-24-4liver diseasesMESH:D008107marker/mechanism10918425
C0023895ticlopidineD01398855142-85-3liver diseasesMESH:D008107marker/mechanism9798669
C0023895tretinoinD014212302-79-4liver diseasesMESH:D008107marker/mechanism18275266
C0023895trimethoprimD014295738-70-5liver diseasesMESH:D008107marker/mechanism7479194
C0023895valproic acidD01463599-66-1liver diseasesMESH:D008107marker/mechanism3092003
C0023895vincristineD014750-liver diseasesMESH:D008107marker/mechanism169340
C0023895vitamin aD01480111103-57-4liver diseasesMESH:D008107marker/mechanism10424294
C0023895vitamin eD0148101406-18-4liver diseasesMESH:D008107therapeutic18377885
C0023895zidovudineD01521530516-87-1liver diseasesMESH:D008107marker/mechanism8004891
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)